[
  {
    "bcr_patient_uuid": "c8802713-b814-4b55-993f-3ffebf8c3ab8",
    "patient_ID": "TCGA.18.3412",
    "bcr_drug_barcode": "TCGA-18-3412-D69102",
    "bcr_drug_uuid": "C4E06ED4-54B7-4025-A17F-CFF5937F2B8E",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c8802713-b814-4b55-993f-3ffebf8c3ab8",
    "patient_ID": "TCGA.18.3412",
    "bcr_drug_barcode": "TCGA-18-3412-D69103",
    "bcr_drug_uuid": "2CDD95C7-2C43-4511-A840-2BD14EDFDF3B",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c8802713-b814-4b55-993f-3ffebf8c3ab8",
    "patient_ID": "TCGA.18.3412",
    "bcr_drug_barcode": "TCGA-18-3412-D69104",
    "bcr_drug_uuid": "88067AFE-D1FA-4DD8-8925-16C65BAD165F",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "TARCEVA/ERLOTINIB",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 301,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a874b64-d0d6-416e-97bc-e9071ed0b16b",
    "patient_ID": "TCGA.18.3415",
    "bcr_drug_barcode": "TCGA-18-3415-D67629",
    "bcr_drug_uuid": "F1AC6A9E-D576-417C-983B-E8D1AED078B8",
    "form_completion_date": "2014-11-7",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a874b64-d0d6-416e-97bc-e9071ed0b16b",
    "patient_ID": "TCGA.18.3415",
    "bcr_drug_barcode": "TCGA-18-3415-D67630",
    "bcr_drug_uuid": "13821C6D-01CF-41E5-93E7-6F7B848F4391",
    "form_completion_date": "2014-11-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 95,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a874b64-d0d6-416e-97bc-e9071ed0b16b",
    "patient_ID": "TCGA.18.3415",
    "bcr_drug_barcode": "TCGA-18-3415-D67631",
    "bcr_drug_uuid": "17749743-6117-43AE-8421-06703FADDCF0",
    "form_completion_date": "2014-11-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "days_to_drug_start": 130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e28cbc9a-aa60-4bfb-8d89-8c33ee97f560",
    "patient_ID": "TCGA.18.3417",
    "bcr_drug_barcode": "TCGA-18-3417-D67646",
    "bcr_drug_uuid": "10CBEAB3-0DCC-4770-897E-54C6637E85B6",
    "form_completion_date": "2014-11-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e28cbc9a-aa60-4bfb-8d89-8c33ee97f560",
    "patient_ID": "TCGA.18.3417",
    "bcr_drug_barcode": "TCGA-18-3417-D67649",
    "bcr_drug_uuid": "EFAD0243-2CF5-4B18-B932-1A261E599E69",
    "form_completion_date": "2014-11-7",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a33f0741-2161-4818-89f2-ec8ccae57949",
    "patient_ID": "TCGA.18.4083",
    "bcr_drug_barcode": "TCGA-18-4083-D69115",
    "bcr_drug_uuid": "650EFD8E-467B-4157-A600-B64EEF506236",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a33f0741-2161-4818-89f2-ec8ccae57949",
    "patient_ID": "TCGA.18.4083",
    "bcr_drug_barcode": "TCGA-18-4083-D69116",
    "bcr_drug_uuid": "DF394533-9B5D-43DA-8B65-12685483FB82",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "211bb982-16f4-4f07-b24f-e633703f24c4",
    "patient_ID": "TCGA.22.4591",
    "bcr_drug_barcode": "TCGA-22-4591-D5693",
    "bcr_drug_uuid": "866d1a7a-01a3-4e14-b1fb-7157a090005c",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 535,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 535,
    "drug_cycles": 2,
    "drug_units": "MG/M2/WK",
    "drug_tota_dose_units": "MG/M2/WK",
    "drug_dose": 2000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D7416",
    "bcr_drug_uuid": "0d243810-3511-4135-b997-4352c2a20d90",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 609,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 637,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 1000,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D7404",
    "bcr_drug_uuid": "faf553bc-2296-4669-a98e-b6b71998a48d",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 340,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D7406",
    "bcr_drug_uuid": "bed8daec-0ea6-4e34-aa49-7987149a6b06",
    "form_completion_date": "2011-2-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 401,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D7420",
    "bcr_drug_uuid": "7ef755b6-7cd5-45a5-b1f5-94a7885613e2",
    "form_completion_date": "2011-2-9",
    "pharmaceutical_therapy_drug_name": "IRESSA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 675,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 724,
    "drug_units": "MG/DAY",
    "drug_dose": 250,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D14619",
    "bcr_drug_uuid": "71c4f1a9-3604-439c-aa88-835507c96d7a",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 340,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D14622",
    "bcr_drug_uuid": "305d1ca3-71a4-452b-9a25-d95cdb7bc3c9",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "RAS INHIBITOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 675,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 724,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D14621",
    "bcr_drug_uuid": "b3ff04b9-6349-4655-a20e-6686a903e29d",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 609,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 637,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "aa53c701-4b65-4c26-a6f0-02a4498717a8",
    "patient_ID": "TCGA.22.4595",
    "bcr_drug_barcode": "TCGA-22-4595-D14620",
    "bcr_drug_uuid": "607ddb8d-8bc8-42ee-b40c-92feba473bea",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 401,
    "drug_cycles": 4,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0c80ab20-7e33-4f1d-b136-07782b68e98b",
    "patient_ID": "TCGA.22.4604",
    "bcr_drug_barcode": "TCGA-22-4604-D7525",
    "bcr_drug_uuid": "235605d2-8335-4d0a-8656-46cb55e9be7f",
    "form_completion_date": "2010-12-2",
    "pharmaceutical_therapy_drug_name": "IRESSA PLACEBO VS. DRUG",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_tota_dose_units": "MG/M2/DAY",
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D11173",
    "bcr_drug_uuid": "9c5a8d73-8dad-46fb-8ee1-435776f9ff19",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1307,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_dose": 2,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENCE OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D11185",
    "bcr_drug_uuid": "6726e342-4e33-4eeb-a0bf-bd7dc91c307b",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "CAV TRIAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1778,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1929,
    "drug_cycles": 4,
    "regimen_number": 5,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION OF SMALL CELL LUNG CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D11175",
    "bcr_drug_uuid": "004efe9f-73d6-4bdb-a227-b8112d3c20ef",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "VP-16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1440,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1594,
    "drug_units": "MG/DAY",
    "drug_dose": 100,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENCE OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D11183",
    "bcr_drug_uuid": "3930b66d-639c-45ae-819a-c654a37cfc27",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1594,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1778,
    "regimen_number": 4,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D11169",
    "bcr_drug_uuid": "3d025236-970d-401b-abb5-eaa5d885afaf",
    "form_completion_date": "2011-5-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 915,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 986,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENCE OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D15157",
    "bcr_drug_uuid": "04a0b97f-9d27-4269-a5fa-b49c14900882",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "IRONOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1307,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENCE OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D15155",
    "bcr_drug_uuid": "57f6cb55-419d-40e7-ad33-43e96d2e9441",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 915,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 986,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENCE OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "bd3bf142-7c14-4538-8a76-3c6e140fa01a",
    "patient_ID": "TCGA.22.5472",
    "bcr_drug_barcode": "TCGA-22-5472-D15162",
    "bcr_drug_uuid": "191ad296-c693-451e-8a03-4c51e75b1f1d",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1594,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1778,
    "regimen_number": 4,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION OF SMALL CELL CARCINOMA"
  },
  {
    "bcr_patient_uuid": "eea9575a-c842-4a95-9e47-3a3b12533f25",
    "patient_ID": "TCGA.22.5473",
    "bcr_drug_barcode": "TCGA-22-5473-D11134",
    "bcr_drug_uuid": "9bc57a27-162c-4a5a-83da-bce375d2d61c",
    "form_completion_date": "2011-5-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fadd20a1-90ca-4d99-a128-9730d02a7bd6",
    "patient_ID": "TCGA.22.5479",
    "bcr_drug_barcode": "TCGA-22-5479-D17880",
    "bcr_drug_uuid": "bf05b90d-1186-4d8a-91af-2cf8bf6ec205",
    "form_completion_date": "2011-10-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 320,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fadd20a1-90ca-4d99-a128-9730d02a7bd6",
    "patient_ID": "TCGA.22.5479",
    "bcr_drug_barcode": "TCGA-22-5479-D17881",
    "bcr_drug_uuid": "7c3430e2-e149-4fb0-abba-433021a42f6d",
    "form_completion_date": "2011-10-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_dose": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "396932ab-c4b3-4526-9201-9222f5f062a5",
    "patient_ID": "TCGA.22.5480",
    "bcr_drug_barcode": "TCGA-22-5480-D11299",
    "bcr_drug_uuid": "b5be39a7-b929-40bd-90c4-837f9b4c7a28",
    "form_completion_date": "2011-5-6",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1995,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2021,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_dose": 30,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "396932ab-c4b3-4526-9201-9222f5f062a5",
    "patient_ID": "TCGA.22.5480",
    "bcr_drug_barcode": "TCGA-22-5480-D11300",
    "bcr_drug_uuid": "c000dae7-1b97-40a3-87dc-358d823823c3",
    "form_completion_date": "2011-5-6",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2036,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2062,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_dose": 75,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "396932ab-c4b3-4526-9201-9222f5f062a5",
    "patient_ID": "TCGA.22.5480",
    "bcr_drug_barcode": "TCGA-22-5480-D11298",
    "bcr_drug_uuid": "d4fb534c-e91b-4700-950c-26e1dfbf151f",
    "form_completion_date": "2011-5-6",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1833,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1937,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "b162b3bf-8097-4466-b08f-6434f541038f",
    "patient_ID": "TCGA.22.5483",
    "bcr_drug_barcode": "TCGA-22-5483-D11478",
    "bcr_drug_uuid": "9d3e017a-3e4b-4c1d-a10a-75c7652fd139",
    "form_completion_date": "2011-5-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1160
  },
  {
    "bcr_patient_uuid": "b162b3bf-8097-4466-b08f-6434f541038f",
    "patient_ID": "TCGA.22.5483",
    "bcr_drug_barcode": "TCGA-22-5483-D14623",
    "bcr_drug_uuid": "f037f6ea-e0a2-4ca7-9e95-a3296694d7ab",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "df6a7005-92ed-4701-bd59-7b5f09715f9d",
    "patient_ID": "TCGA.22.5489",
    "bcr_drug_barcode": "TCGA-22-5489-D11538",
    "bcr_drug_uuid": "0cd8ef98-3dab-4c8e-badb-3b120b00d470",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 855,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "df6a7005-92ed-4701-bd59-7b5f09715f9d",
    "patient_ID": "TCGA.22.5489",
    "bcr_drug_barcode": "TCGA-22-5489-D11537",
    "bcr_drug_uuid": "5c54cf3f-2029-46be-852e-07e56c24af75",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 776,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "df6a7005-92ed-4701-bd59-7b5f09715f9d",
    "patient_ID": "TCGA.22.5489",
    "bcr_drug_barcode": "TCGA-22-5489-D14624",
    "bcr_drug_uuid": "b97ecce5-67c9-4153-84c8-9d8b04227baf",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 776,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "drug_cycles": 3,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "df6a7005-92ed-4701-bd59-7b5f09715f9d",
    "patient_ID": "TCGA.22.5489",
    "bcr_drug_barcode": "TCGA-22-5489-D14625",
    "bcr_drug_uuid": "aba67dd8-15e5-469e-b33e-5f83eccec976",
    "form_completion_date": "2011-8-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 855,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 855,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D29093",
    "bcr_drug_uuid": "907cc48b-f6ff-495b-a834-e95405e6f8ad",
    "form_completion_date": "2003-3-8",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG/KG/DAY",
    "drug_dose": 4,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D22053",
    "bcr_drug_uuid": "14384be6-7f00-4b9c-a10d-8b5b93bad190",
    "form_completion_date": "2012-3-2",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE (VP-16)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D29092",
    "bcr_drug_uuid": "df1332c7-ca9f-407c-8089-e76bd5148bb5",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "G/DAY",
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D29091",
    "bcr_drug_uuid": "88966918-f2a9-469d-b28f-4b8aed5144bd",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "drug_units": "G/DAY",
    "drug_dose": 1,
    "regimen_number": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D29094",
    "bcr_drug_uuid": "9100e3bb-00a9-4f1f-91da-fe21afd7a2b7",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG/ML",
    "drug_dose": 6,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D29088",
    "bcr_drug_uuid": "48e5b716-7ca7-44c0-93d1-3c7725cfa9af",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 93,
    "drug_cycles": 1,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46cc3a2b-91c9-4a74-8989-992585634b87",
    "patient_ID": "TCGA.33.4587",
    "bcr_drug_barcode": "TCGA-33-4587-D29089",
    "bcr_drug_uuid": "159c6f3f-d037-49db-807a-f74dfb1c17f6",
    "form_completion_date": "2012-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 1,
    "drug_tota_dose_units": "MG/M2",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "afedf3fb-fc77-45a7-bdcd-2c78706a0f8a",
    "patient_ID": "TCGA.33.6737",
    "bcr_drug_barcode": "TCGA-33-6737-D17177",
    "bcr_drug_uuid": "6baf6093-00f8-412e-88c8-7ebe8e34a35a",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "afedf3fb-fc77-45a7-bdcd-2c78706a0f8a",
    "patient_ID": "TCGA.33.6737",
    "bcr_drug_barcode": "TCGA-33-6737-D17176",
    "bcr_drug_uuid": "db5da90b-d6e6-427b-90f4-8223c3eb7162",
    "form_completion_date": "2011-10-4",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb6065de-0fc2-40e6-9609-179dfc54943f",
    "patient_ID": "TCGA.33.6738",
    "bcr_drug_barcode": "TCGA-33-6738-D15031",
    "bcr_drug_uuid": "838e4a45-a4e8-4b4e-a81c-c5821c3a2720",
    "form_completion_date": "2011-8-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb6065de-0fc2-40e6-9609-179dfc54943f",
    "patient_ID": "TCGA.33.6738",
    "bcr_drug_barcode": "TCGA-33-6738-D16688",
    "bcr_drug_uuid": "308dad8a-155c-4927-a160-d27afca0ec18",
    "form_completion_date": "2011-9-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "55BAFAAD-323B-4B92-813E-52D18D70FC3E",
    "patient_ID": "TCGA.33.AASI",
    "bcr_drug_barcode": "TCGA-33-AASI-D64998",
    "bcr_drug_uuid": "C630A1CC-8E2B-4990-BA84-F83DC8A38A24",
    "form_completion_date": "2014-9-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "55BAFAAD-323B-4B92-813E-52D18D70FC3E",
    "patient_ID": "TCGA.33.AASI",
    "bcr_drug_barcode": "TCGA-33-AASI-D64999",
    "bcr_drug_uuid": "8857466A-8AD5-472C-8399-A5CD3401FA1B",
    "form_completion_date": "2014-9-17",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9335e4df-9974-47ec-84c4-256cd33522f2",
    "patient_ID": "TCGA.34.2605",
    "bcr_drug_barcode": "TCGA-34-2605-D4241",
    "bcr_drug_uuid": "e04dce71-ae03-486a-8a97-9b3075fe230e",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "9335e4df-9974-47ec-84c4-256cd33522f2",
    "patient_ID": "TCGA.34.2605",
    "bcr_drug_barcode": "TCGA-34-2605-D4242",
    "bcr_drug_uuid": "d7df10cb-4fbb-469f-8361-e87c9e7df312",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 88,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 88
  },
  {
    "bcr_patient_uuid": "257650bd-2e2b-4680-b77b-f9268b3af4ee",
    "patient_ID": "TCGA.34.2609",
    "bcr_drug_barcode": "TCGA-34-2609-D4230",
    "bcr_drug_uuid": "3810d316-bcb7-4974-9c1c-bbe5d6088ebb",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 660,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 856,
    "drug_units": "MG/M2",
    "drug_dose": 20,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "257650bd-2e2b-4680-b77b-f9268b3af4ee",
    "patient_ID": "TCGA.34.2609",
    "bcr_drug_barcode": "TCGA-34-2609-D4231",
    "bcr_drug_uuid": "0a7f6405-d527-4141-a2c3-5466cd981156",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 905,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 912,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "257650bd-2e2b-4680-b77b-f9268b3af4ee",
    "patient_ID": "TCGA.34.2609",
    "bcr_drug_barcode": "TCGA-34-2609-D4233",
    "bcr_drug_uuid": "f10c766e-6ced-4522-82bd-1122477d304d",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "257650bd-2e2b-4680-b77b-f9268b3af4ee",
    "patient_ID": "TCGA.34.2609",
    "bcr_drug_barcode": "TCGA-34-2609-D4235",
    "bcr_drug_uuid": "d699984b-63a3-4d6c-9986-34bc5cd7f7b8",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 464,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 569,
    "drug_cycles": 6,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "257650bd-2e2b-4680-b77b-f9268b3af4ee",
    "patient_ID": "TCGA.34.2609",
    "bcr_drug_barcode": "TCGA-34-2609-D4232",
    "bcr_drug_uuid": "6e5970e6-f214-4603-9369-382c3ed1fa1c",
    "form_completion_date": "2010-11-4",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4631400b-1c96-4074-b779-7cbc77a49d99",
    "patient_ID": "TCGA.34.5239",
    "bcr_drug_barcode": "TCGA-34-5239-D70382",
    "bcr_drug_uuid": "98D486C7-B559-42D9-B6C6-A12CB9E20B9C",
    "form_completion_date": "2015-2-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1811,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7d1b042-5b1c-4c29-b501-a5ef4810ecd2",
    "patient_ID": "TCGA.34.5240",
    "bcr_drug_barcode": "TCGA-34-5240-D32184",
    "bcr_drug_uuid": "438C956F-7388-49AC-8481-B4539EAD5862",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7d1b042-5b1c-4c29-b501-a5ef4810ecd2",
    "patient_ID": "TCGA.34.5240",
    "bcr_drug_barcode": "TCGA-34-5240-D32185",
    "bcr_drug_uuid": "556A6EAD-B090-40C5-B986-2E678C7DF5C0",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "18f18672-2a23-4e26-987b-38c454ff46c7",
    "patient_ID": "TCGA.34.5927",
    "bcr_drug_barcode": "TCGA-34-5927-D72567",
    "bcr_drug_uuid": "277B3014-BB2F-4464-B4DE-635406FCC5D4",
    "form_completion_date": "2015-7-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "18f18672-2a23-4e26-987b-38c454ff46c7",
    "patient_ID": "TCGA.34.5927",
    "bcr_drug_barcode": "TCGA-34-5927-D72568",
    "bcr_drug_uuid": "898716B4-DCBC-41DD-B9EF-7DB5E758FA63",
    "form_completion_date": "2015-7-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 292,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 385,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "059212b3-9e71-4d00-863f-3639c4e30ed1",
    "patient_ID": "TCGA.34.8454",
    "bcr_drug_barcode": "TCGA-34-8454-D56118",
    "bcr_drug_uuid": "6AE123CC-A841-49FF-82B3-364D2F2203DC",
    "form_completion_date": "2014-1-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "059212b3-9e71-4d00-863f-3639c4e30ed1",
    "patient_ID": "TCGA.34.8454",
    "bcr_drug_barcode": "TCGA-34-8454-D69228",
    "bcr_drug_uuid": "C9C9AE41-AAAD-4E3B-BF53-0F5911C456CB",
    "form_completion_date": "2014-12-30",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AECD6689-F203-4519-AFAB-3F46EE9D3E2C",
    "patient_ID": "TCGA.37.A5EL",
    "bcr_drug_barcode": "TCGA-37-A5EL-D72519",
    "bcr_drug_uuid": "7B1CC5D3-BB08-46A8-9158-57B6E7682D2C",
    "form_completion_date": "2015-7-9",
    "pharmaceutical_therapy_drug_name": "TEMODAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 222,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5845fe49-f2cc-436b-9ec8-65e775eae111",
    "patient_ID": "TCGA.39.5011",
    "bcr_drug_barcode": "TCGA-39-5011-D8446",
    "bcr_drug_uuid": "6c4e5fa7-2382-4184-93ef-efadede1a3e4",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 621,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "5845fe49-f2cc-436b-9ec8-65e775eae111",
    "patient_ID": "TCGA.39.5011",
    "bcr_drug_barcode": "TCGA-39-5011-D8444",
    "bcr_drug_uuid": "cecf5107-6f93-4f7e-9ff7-baf93ae12063",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 621,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 78,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 156
  },
  {
    "bcr_patient_uuid": "5845fe49-f2cc-436b-9ec8-65e775eae111",
    "patient_ID": "TCGA.39.5011",
    "bcr_drug_barcode": "TCGA-39-5011-D8443",
    "bcr_drug_uuid": "7ca8d9e4-95ed-49df-8cab-ae8577321258",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 728,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 742,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 48,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 144
  },
  {
    "bcr_patient_uuid": "5845fe49-f2cc-436b-9ec8-65e775eae111",
    "patient_ID": "TCGA.39.5011",
    "bcr_drug_barcode": "TCGA-39-5011-D72540",
    "bcr_drug_uuid": "EEFCA703-A5C1-4A50-BEEC-7A58328EBF4B",
    "form_completion_date": "2015-7-13",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 677,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 677,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e7020168-1afe-4361-800a-8979aafca12a",
    "patient_ID": "TCGA.39.5021",
    "bcr_drug_barcode": "TCGA-39-5021-D8454",
    "bcr_drug_uuid": "c62cbcf6-692b-493c-b57c-c69f8d2102e2",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1903,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2016,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2360
  },
  {
    "bcr_patient_uuid": "e7020168-1afe-4361-800a-8979aafca12a",
    "patient_ID": "TCGA.39.5021",
    "bcr_drug_barcode": "TCGA-39-5021-D8455",
    "bcr_drug_uuid": "0b154f6b-a2b9-4dbf-86a6-149ee6d56dbe",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1902,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2015,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 960
  },
  {
    "bcr_patient_uuid": "3a74420c-9ee6-4131-8aff-7265b047e6a8",
    "patient_ID": "TCGA.39.5024",
    "bcr_drug_barcode": "TCGA-39-5024-D17352",
    "bcr_drug_uuid": "1f3cc98b-20a7-4e27-b447-14eb238776b1",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3a74420c-9ee6-4131-8aff-7265b047e6a8",
    "patient_ID": "TCGA.39.5024",
    "bcr_drug_barcode": "TCGA-39-5024-D17353",
    "bcr_drug_uuid": "37666a90-faf0-4689-a1eb-fd6fc4cd612b",
    "form_completion_date": "2011-10-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8474",
    "bcr_drug_uuid": "43f12bb3-5549-4ddc-ba7b-4ba270266d89",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 658,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 672,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 46,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 93
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8476",
    "bcr_drug_uuid": "cc245765-e385-4e99-9b4a-0f351cf023fb",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 700,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8477",
    "bcr_drug_uuid": "763a58f3-c943-4d95-aa81-85caa910b18d",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 700,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 707,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8479",
    "bcr_drug_uuid": "02d9cdfe-792a-4f3b-9baf-7ca55c4d95c2",
    "form_completion_date": "2010-12-4",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 707,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 707,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 750,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8465",
    "bcr_drug_uuid": "84c0db91-78c8-4c11-83b1-13277602f345",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8467",
    "bcr_drug_uuid": "ea26fa13-0c52-40b7-87b0-a485d962a0bf",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "PEMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 514,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 535,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8472",
    "bcr_drug_uuid": "6908c0e3-8bc5-4d7a-a111-691139e91a4d",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 645,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 658,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8475",
    "bcr_drug_uuid": "9f10ef1f-7a1d-429e-b23c-e96c5c0370f8",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 672,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 672,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 47,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 47
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8469",
    "bcr_drug_uuid": "f2e40d60-5cac-426d-ad86-24a1852ef5ee",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 672,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 672,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1900,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 1900
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8480",
    "bcr_drug_uuid": "cd41f6fc-2fb2-4ca0-8b57-cbe1d5d6a05d",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 707,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 707,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8478",
    "bcr_drug_uuid": "516143b0-8dc2-47af-89fb-fa266890d325",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 707,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 707,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 460,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PALLIATIVE",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "2f39e89c-a8f7-4df8-a0f5-ef9990c2133c",
    "patient_ID": "TCGA.39.5029",
    "bcr_drug_barcode": "TCGA-39-5029-D8466",
    "bcr_drug_uuid": "951e4ab1-1010-4a41-b6e0-933cd2388dd0",
    "form_completion_date": "2011-2-11",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "02eb85cc-a597-4eaa-9614-c94c0f035929",
    "patient_ID": "TCGA.39.5037",
    "bcr_drug_barcode": "TCGA-39-5037-D8509",
    "bcr_drug_uuid": "d7681e14-037c-4a0b-9a5b-ce78eb5d63aa",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "02eb85cc-a597-4eaa-9614-c94c0f035929",
    "patient_ID": "TCGA.39.5037",
    "bcr_drug_barcode": "TCGA-39-5037-D8510",
    "bcr_drug_uuid": "c6764437-551c-4328-a804-c4f519fdddd8",
    "form_completion_date": "2010-12-6",
    "pharmaceutical_therapy_drug_name": "GEMZAR (GEMCITABINE)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 63,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3200
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29967",
    "bcr_drug_uuid": "032E2FA9-D68E-4DEF-87B2-672C20797240",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 850
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29969",
    "bcr_drug_uuid": "4D05ADEE-5B32-4992-9964-10BB6C86588C",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29971",
    "bcr_drug_uuid": "AEB2E38F-679D-4D2B-BD69-159CA771F879",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 24,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29970",
    "bcr_drug_uuid": "5D25411D-2F5E-4602-8557-18ED337027FE",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 24,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29968",
    "bcr_drug_uuid": "056DBE52-9448-430F-BE24-7D392BE78D5B",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 5,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29966",
    "bcr_drug_uuid": "D72B7B41-75C7-412A-A876-16D992086DAB",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "eca4bfa2-5ba5-4708-959a-d901c1b61edd",
    "patient_ID": "TCGA.39.5040",
    "bcr_drug_barcode": "TCGA-39-5040-D29965",
    "bcr_drug_uuid": "AB287A86-34B0-420E-921A-1A84C225ADFB",
    "form_completion_date": "2012-3-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 25,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "0806923c-2dee-403d-a2e9-771722873b0d",
    "patient_ID": "TCGA.43.2576",
    "bcr_drug_barcode": "TCGA-43-2576-D4986",
    "bcr_drug_uuid": "0a69fa67-1949-4458-9deb-ed87976d88a1",
    "form_completion_date": "2010-10-19",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "0806923c-2dee-403d-a2e9-771722873b0d",
    "patient_ID": "TCGA.43.2576",
    "bcr_drug_barcode": "TCGA-43-2576-D4987",
    "bcr_drug_uuid": "b0a5867b-1e3d-4d0f-9c6b-a22707dcd0aa",
    "form_completion_date": "2010-10-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "0806923c-2dee-403d-a2e9-771722873b0d",
    "patient_ID": "TCGA.43.2576",
    "bcr_drug_barcode": "TCGA-43-2576-D4988",
    "bcr_drug_uuid": "26c4e329-2f13-4afc-8d17-1d16f142f2f4",
    "form_completion_date": "2010-10-19",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 35,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 310
  },
  {
    "bcr_patient_uuid": "ad112acb-d241-48a0-8e48-d69cdc3feba8",
    "patient_ID": "TCGA.43.2581",
    "bcr_drug_barcode": "TCGA-43-2581-D5006",
    "bcr_drug_uuid": "c1af6388-922d-49c8-be29-e835200d7ed7",
    "form_completion_date": "2010-10-19",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 700,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2800
  },
  {
    "bcr_patient_uuid": "ad112acb-d241-48a0-8e48-d69cdc3feba8",
    "patient_ID": "TCGA.43.2581",
    "bcr_drug_barcode": "TCGA-43-2581-D5007",
    "bcr_drug_uuid": "9c452164-5752-43b0-8ae5-b7352cfbc49a",
    "form_completion_date": "2010-10-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "ce8612ab-3149-4a6a-b424-29c0c21c9b8b",
    "patient_ID": "TCGA.43.3394",
    "bcr_drug_barcode": "TCGA-43-3394-D4990",
    "bcr_drug_uuid": "1c332355-d199-4861-9af9-5b6340413f27",
    "form_completion_date": "2010-10-20",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20800
  },
  {
    "bcr_patient_uuid": "ce8612ab-3149-4a6a-b424-29c0c21c9b8b",
    "patient_ID": "TCGA.43.3394",
    "bcr_drug_barcode": "TCGA-43-3394-D4991",
    "bcr_drug_uuid": "ecc7a5bd-a6a3-4e28-9f30-d32f749072c9",
    "form_completion_date": "2010-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 154,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 750,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "ce8612ab-3149-4a6a-b424-29c0c21c9b8b",
    "patient_ID": "TCGA.43.3394",
    "bcr_drug_barcode": "TCGA-43-3394-D18315",
    "bcr_drug_uuid": "4f13cda1-41a6-446b-9c7f-e0405469a995",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 574,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 581,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_dose": 65,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "ce8612ab-3149-4a6a-b424-29c0c21c9b8b",
    "patient_ID": "TCGA.43.3394",
    "bcr_drug_barcode": "TCGA-43-3394-D18316",
    "bcr_drug_uuid": "99e7992f-e666-4916-aa93-9d7bfe31deb2",
    "form_completion_date": "2011-11-10",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 588,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 616,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "f5ad138c-1714-41e9-9c2d-c88050bec407",
    "patient_ID": "TCGA.43.5668",
    "bcr_drug_barcode": "TCGA-43-5668-D13457",
    "bcr_drug_uuid": "4324eaea-bc4a-4a45-b780-552718e2583c",
    "form_completion_date": "2011-6-28",
    "pharmaceutical_therapy_drug_name": "CLINICAL TRIAL",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 7,
    "pharma_type_other": "MAGE3-AS15-NSC-003",
    "drug_units": "ML",
    "drug_dose": 0.5,
    "regimen_number": 1,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f5ad138c-1714-41e9-9c2d-c88050bec407",
    "patient_ID": "TCGA.43.5668",
    "bcr_drug_barcode": "TCGA-43-5668-D31291",
    "bcr_drug_uuid": "B7A88E76-16BF-434C-A605-FCFF4BAA21CA",
    "form_completion_date": "2012-4-27",
    "pharmaceutical_therapy_drug_name": "REC MAGE3-AS+AS15 ASCI VS PLACEBO",
    "pharmaceutical_therapy_type": "VACCINE",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 446,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "f5ad138c-1714-41e9-9c2d-c88050bec407",
    "patient_ID": "TCGA.43.5668",
    "bcr_drug_barcode": "TCGA-43-5668-D31292",
    "bcr_drug_uuid": "E44C56C7-883C-4560-BFBD-D8C992F20603",
    "form_completion_date": "2012-4-27",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 481,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 551,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7d905f8f-3967-4ea8-96c8-17b1b03fbec3",
    "patient_ID": "TCGA.43.5670",
    "bcr_drug_barcode": "TCGA-43-5670-D28646",
    "bcr_drug_uuid": "491c28d2-5d14-4330-85bc-3c16d8e9a53d",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 415
  },
  {
    "bcr_patient_uuid": "7d905f8f-3967-4ea8-96c8-17b1b03fbec3",
    "patient_ID": "TCGA.43.5670",
    "bcr_drug_barcode": "TCGA-43-5670-D28648",
    "bcr_drug_uuid": "674a0e35-e0f2-4277-966f-03b495f02fc7",
    "form_completion_date": "2012-2-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 415
  },
  {
    "bcr_patient_uuid": "a8764401-d2a5-45dd-941d-2ffb2e7a4664",
    "patient_ID": "TCGA.43.6143",
    "bcr_drug_barcode": "TCGA-43-6143-D20949",
    "bcr_drug_uuid": "c42acc0d-1b78-499b-85a0-bdaeb926b66c",
    "form_completion_date": "2012-1-25",
    "pharmaceutical_therapy_drug_name": "RECMAGE3-AS+AS15 ASCI/PLACEBO VACCINE",
    "pharmaceutical_therapy_type": "OTHER, SPECIFY IN NOTES",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 7,
    "pharma_type_other": "VACCINE",
    "drug_units": "ML",
    "drug_dose": 0.5,
    "regimen_number": 1,
    "drug_route": "INTRAMUSCULAR",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "40e928e8-bedd-4b86-81bc-b581bfc897d4",
    "patient_ID": "TCGA.43.6647",
    "bcr_drug_barcode": "TCGA-43-6647-D39007",
    "bcr_drug_uuid": "DDB4549A-5D4F-4E62-90EC-22EEB9E1F68F",
    "form_completion_date": "2013-1-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "40e928e8-bedd-4b86-81bc-b581bfc897d4",
    "patient_ID": "TCGA.43.6647",
    "bcr_drug_barcode": "TCGA-43-6647-D39008",
    "bcr_drug_uuid": "2082F424-9D4C-44E3-96D9-BAD10FDCDC08",
    "form_completion_date": "2013-1-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "381edbe7-f391-4154-b16e-ac91d550582e",
    "patient_ID": "TCGA.43.6770",
    "bcr_drug_barcode": "TCGA-43-6770-D34029",
    "bcr_drug_uuid": "8C154C07-B173-4FCF-82C7-E25AE2548B90",
    "form_completion_date": "2012-7-26",
    "pharmaceutical_therapy_drug_name": "RECPRAME+AS15",
    "clinical_trial_drug_classification": "ANTIGEN SPECIFIC CANCER IMMUNOTHERAPEUTIC THERAPY",
    "pharmaceutical_therapy_type": "VACCINE",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0e084325-ba97-4c0a-9d00-12d01b4bc0bb",
    "patient_ID": "TCGA.43.8115",
    "bcr_drug_barcode": "TCGA-43-8115-D32445",
    "bcr_drug_uuid": "1df8e8f1-4bda-4619-bad6-7710cf1e8e27",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0e084325-ba97-4c0a-9d00-12d01b4bc0bb",
    "patient_ID": "TCGA.43.8115",
    "bcr_drug_barcode": "TCGA-43-8115-D32446",
    "bcr_drug_uuid": "3c74267b-6a9f-48df-a756-e3bd51b326e7",
    "form_completion_date": "2012-5-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ad98977b-e159-410a-b8c2-f4e8a07f9784",
    "patient_ID": "TCGA.43.8118",
    "bcr_drug_barcode": "TCGA-43-8118-D36574",
    "bcr_drug_uuid": "F0203150-A989-4E9B-A81C-E5BA2C58F29B",
    "form_completion_date": "2012-11-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ad98977b-e159-410a-b8c2-f4e8a07f9784",
    "patient_ID": "TCGA.43.8118",
    "bcr_drug_barcode": "TCGA-43-8118-D36575",
    "bcr_drug_uuid": "D9DD190F-FDC1-4F3E-9C17-DBA409E9DDF8",
    "form_completion_date": "2012-11-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 82,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AE2C650C-600B-4C58-893B-7FD73D44AF47",
    "patient_ID": "TCGA.43.A474",
    "bcr_drug_barcode": "TCGA-43-A474-D37080",
    "bcr_drug_uuid": "845EAC18-C727-4CFE-BA04-6A068BB970AF",
    "form_completion_date": "2012-11-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AE2C650C-600B-4C58-893B-7FD73D44AF47",
    "patient_ID": "TCGA.43.A474",
    "bcr_drug_barcode": "TCGA-43-A474-D37081",
    "bcr_drug_uuid": "F29D1667-A937-43BA-BE77-E4C62F4A0216",
    "form_completion_date": "2012-11-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA7B9B84-C227-4AD0-9E71-88EE3309162C",
    "patient_ID": "TCGA.43.A475",
    "bcr_drug_barcode": "TCGA-43-A475-D37108",
    "bcr_drug_uuid": "B4808E6D-57FF-4965-991C-FD0813625EBC",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BA7B9B84-C227-4AD0-9E71-88EE3309162C",
    "patient_ID": "TCGA.43.A475",
    "bcr_drug_barcode": "TCGA-43-A475-D37109",
    "bcr_drug_uuid": "9AC6843E-FE86-40ED-B200-5B3A41AE6931",
    "form_completion_date": "2012-11-26",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB2A7057-6DF5-4EB9-AD0F-9AC47314889E",
    "patient_ID": "TCGA.43.A56V",
    "bcr_drug_barcode": "TCGA-43-A56V-D41938",
    "bcr_drug_uuid": "22E0EB20-6263-4BA5-973E-CCF6DCAF5A15",
    "form_completion_date": "2013-4-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB2A7057-6DF5-4EB9-AD0F-9AC47314889E",
    "patient_ID": "TCGA.43.A56V",
    "bcr_drug_barcode": "TCGA-43-A56V-D41939",
    "bcr_drug_uuid": "898B239C-847F-4C11-8A53-5FA888C4B6ED",
    "form_completion_date": "2013-4-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a402e786-132c-4095-bb75-22be04b5d835",
    "patient_ID": "TCGA.46.3768",
    "bcr_drug_barcode": "TCGA-46-3768-D9040",
    "bcr_drug_uuid": "DB3BD907-7E6B-4E1B-BF0A-7656E481BD0D",
    "form_completion_date": "2011-3-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN/PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d38dbe20-bd5a-45d5-8db3-d5f777b454b6",
    "patient_ID": "TCGA.46.3769",
    "bcr_drug_barcode": "TCGA-46-3769-D9107",
    "bcr_drug_uuid": "5E76029F-F467-4F00-9BD9-4AC4C545F53C",
    "form_completion_date": "2011-3-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN/ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6020ec67-8f3b-409f-a0ed-2af849b4d76f",
    "patient_ID": "TCGA.46.6025",
    "bcr_drug_barcode": "TCGA-46-6025-D13769",
    "bcr_drug_uuid": "dbafd3af-2801-4421-8c3f-b0dd2967fcf8",
    "form_completion_date": "2011-7-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_dose": 185,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6020ec67-8f3b-409f-a0ed-2af849b4d76f",
    "patient_ID": "TCGA.46.6025",
    "bcr_drug_barcode": "TCGA-46-6025-D13770",
    "bcr_drug_uuid": "462e5e5c-9a24-4d08-b2cc-d3886eb960ee",
    "form_completion_date": "2011-7-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_dose": 2470,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e8bc2eea-dc6e-420b-abe8-e36989e75df8",
    "patient_ID": "TCGA.46.6026",
    "bcr_drug_barcode": "TCGA-46-6026-D13766",
    "bcr_drug_uuid": "9fa4ba51-452d-49ce-a2aa-48e9ef1138bf",
    "form_completion_date": "2011-7-13",
    "pharmaceutical_therapy_drug_name": "PARAPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 132,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e8bc2eea-dc6e-420b-abe8-e36989e75df8",
    "patient_ID": "TCGA.46.6026",
    "bcr_drug_barcode": "TCGA-46-6026-D13765",
    "bcr_drug_uuid": "8fb5e58a-057c-4795-8114-e3d6fed98fce",
    "form_completion_date": "2011-7-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_dose": 96,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e8bc2eea-dc6e-420b-abe8-e36989e75df8",
    "patient_ID": "TCGA.46.6026",
    "bcr_drug_barcode": "TCGA-46-6026-D13767",
    "bcr_drug_uuid": "c23f13e8-57a9-4488-a4c4-9d81ec1b9034",
    "form_completion_date": "2011-7-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_dose": 1178,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATIVE"
  },
  {
    "bcr_patient_uuid": "e8bc2eea-dc6e-420b-abe8-e36989e75df8",
    "patient_ID": "TCGA.46.6026",
    "bcr_drug_barcode": "TCGA-46-6026-D13768",
    "bcr_drug_uuid": "00b780a7-2b0a-47c3-845b-6d32d8e690eb",
    "form_completion_date": "2011-7-13",
    "pharmaceutical_therapy_drug_name": "PARAPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_dose": 345,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATIVE"
  },
  {
    "bcr_patient_uuid": "3f43c83e-c2a2-4224-9da0-0757b9c7d4ca",
    "patient_ID": "TCGA.51.4081",
    "bcr_drug_barcode": "TCGA-51-4081-D4651",
    "bcr_drug_uuid": "0a2f2ebb-256d-4c79-9720-06161d17ddb3",
    "form_completion_date": "2010-12-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 60,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3f43c83e-c2a2-4224-9da0-0757b9c7d4ca",
    "patient_ID": "TCGA.51.4081",
    "bcr_drug_barcode": "TCGA-51-4081-D20648",
    "bcr_drug_uuid": "45a30db1-ee68-4a93-907a-9f2b32412f1c",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_dose": 25,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "81b7cbc1-c037-426f-95b0-d729a30697da",
    "patient_ID": "TCGA.52.7812",
    "bcr_drug_barcode": "TCGA-52-7812-D39714",
    "bcr_drug_uuid": "07815A8B-AAFF-4B14-94EC-3B8A077996A0",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 529,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "81b7cbc1-c037-426f-95b0-d729a30697da",
    "patient_ID": "TCGA.52.7812",
    "bcr_drug_barcode": "TCGA-52-7812-D39719",
    "bcr_drug_uuid": "9773E151-B94D-4C6B-8487-0E597A862DE6",
    "form_completion_date": "2013-1-31",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 656,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 797,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3768cf73-e389-449a-bde3-29eb20c9e249",
    "patient_ID": "TCGA.56.7222",
    "bcr_drug_barcode": "TCGA-56-7222-D47056",
    "bcr_drug_uuid": "5E6D7891-A371-4CF7-B374-1644EA8BD452",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3768cf73-e389-449a-bde3-29eb20c9e249",
    "patient_ID": "TCGA.56.7222",
    "bcr_drug_barcode": "TCGA-56-7222-D47057",
    "bcr_drug_uuid": "879A4789-EBD8-44E1-90C6-014A08210189",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3768cf73-e389-449a-bde3-29eb20c9e249",
    "patient_ID": "TCGA.56.7222",
    "bcr_drug_barcode": "TCGA-56-7222-D47058",
    "bcr_drug_uuid": "ABC452D4-7CF4-4D57-B4AF-E18F0BBB60EE",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 519,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3768cf73-e389-449a-bde3-29eb20c9e249",
    "patient_ID": "TCGA.56.7222",
    "bcr_drug_barcode": "TCGA-56-7222-D47059",
    "bcr_drug_uuid": "958724DB-EBDE-4829-AD3E-3ECD9B7A8DAD",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 519,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3768cf73-e389-449a-bde3-29eb20c9e249",
    "patient_ID": "TCGA.56.7222",
    "bcr_drug_barcode": "TCGA-56-7222-D47060",
    "bcr_drug_uuid": "5067E16A-E981-42FC-A32A-B7310630A1C7",
    "form_completion_date": "2013-8-21",
    "pharmaceutical_therapy_drug_name": "REOLYSIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 519,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60116",
    "bcr_drug_uuid": "4B621263-6743-4952-9983-7D721D814A32",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60117",
    "bcr_drug_uuid": "341B3213-33D7-4DA0-936E-896158E8A414",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60118",
    "bcr_drug_uuid": "EC6585FB-918C-4C04-9DB7-4B65DBAADDFC",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 165,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 215,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60119",
    "bcr_drug_uuid": "9669EC70-C336-4CDF-8218-A31BE9DDD7AE",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60120",
    "bcr_drug_uuid": "DA92DB59-C64B-4E4F-A102-C837B696D71D",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 471,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60121",
    "bcr_drug_uuid": "F692688B-DEA4-41C1-A9AC-3453789BD982",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "MK2206",
    "days_to_drug_start": 585,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D60122",
    "bcr_drug_uuid": "CC762C73-CA48-4BA9-8A51-79D88F599013",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 724,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1ccd29c1-cf30-4701-9b50-5d34cae2f4b3",
    "patient_ID": "TCGA.56.7579",
    "bcr_drug_barcode": "TCGA-56-7579-D72569",
    "bcr_drug_uuid": "1CB0D459-7478-4201-812E-9FAA07052A89",
    "form_completion_date": "2015-7-21",
    "pharmaceutical_therapy_drug_name": "AZD6244",
    "days_to_drug_start": 585,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "8bb3ed57-6e48-4c90-bcf2-baf9a843398f",
    "patient_ID": "TCGA.56.7730",
    "bcr_drug_barcode": "TCGA-56-7730-D64298",
    "bcr_drug_uuid": "BC42CBBB-6382-4020-8077-6B4D8503F37E",
    "form_completion_date": "2014-8-28",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f1aa75c3-13f3-4bd9-9e51-923c2f62c2f7",
    "patient_ID": "TCGA.56.7822",
    "bcr_drug_barcode": "TCGA-56-7822-D66154",
    "bcr_drug_uuid": "219F859D-BF30-4DB7-990D-8268E23132FA",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "ELOXATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 311,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 332,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b236171-2e7a-4018-b297-560ea8279ec0",
    "patient_ID": "TCGA.56.7823",
    "bcr_drug_barcode": "TCGA-56-7823-D60129",
    "bcr_drug_uuid": "471CEC7A-35BF-42D0-88D9-DAD0D2D0A96F",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b236171-2e7a-4018-b297-560ea8279ec0",
    "patient_ID": "TCGA.56.7823",
    "bcr_drug_barcode": "TCGA-56-7823-D60130",
    "bcr_drug_uuid": "43855D49-2DDE-4276-B1FF-CC4B8ACF3A9D",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "399c936e-ba68-4040-98d4-917a87dad603",
    "patient_ID": "TCGA.56.8308",
    "bcr_drug_barcode": "TCGA-56-8308-D35778",
    "bcr_drug_uuid": "43B921F2-205B-40CF-96E6-65AE81272CA0",
    "form_completion_date": "2012-10-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "399c936e-ba68-4040-98d4-917a87dad603",
    "patient_ID": "TCGA.56.8308",
    "bcr_drug_barcode": "TCGA-56-8308-D35779",
    "bcr_drug_uuid": "17F4BE6B-23FF-4233-9C41-C03B09E46E91",
    "form_completion_date": "2012-10-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2cc8743a-e759-4250-82be-893376933930",
    "patient_ID": "TCGA.56.8624",
    "bcr_drug_barcode": "TCGA-56-8624-D47794",
    "bcr_drug_uuid": "02973D5E-80D8-452B-8FD1-BB2B8C75475A",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2cc8743a-e759-4250-82be-893376933930",
    "patient_ID": "TCGA.56.8624",
    "bcr_drug_barcode": "TCGA-56-8624-D47795",
    "bcr_drug_uuid": "72D69F4E-7D93-4B93-B1CE-DD53F4B28BD0",
    "form_completion_date": "2013-8-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "234c7de4-ce5b-4a2f-ac46-9da61cff1680",
    "patient_ID": "TCGA.56.8625",
    "bcr_drug_barcode": "TCGA-56-8625-D59029",
    "bcr_drug_uuid": "CBF87725-77BE-423C-AA06-838C1162D36E",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "234c7de4-ce5b-4a2f-ac46-9da61cff1680",
    "patient_ID": "TCGA.56.8625",
    "bcr_drug_barcode": "TCGA-56-8625-D59030",
    "bcr_drug_uuid": "1B80B618-DAC1-41A0-8A07-AD9F437EC8DE",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "234c7de4-ce5b-4a2f-ac46-9da61cff1680",
    "patient_ID": "TCGA.56.8625",
    "bcr_drug_barcode": "TCGA-56-8625-D59032",
    "bcr_drug_uuid": "97548FA9-060F-41A5-A8DF-A48F5BD14325",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f084d72-fbf9-4787-b107-815b481b1a6e",
    "patient_ID": "TCGA.56.8629",
    "bcr_drug_barcode": "TCGA-56-8629-D57033",
    "bcr_drug_uuid": "5CC85BE8-348D-4C9C-801D-404F4D4E356C",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1f084d72-fbf9-4787-b107-815b481b1a6e",
    "patient_ID": "TCGA.56.8629",
    "bcr_drug_barcode": "TCGA-56-8629-D57034",
    "bcr_drug_uuid": "3B5E5BDF-0A84-45F1-BFA3-29AF8826B831",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B838706D-01E9-45AA-869D-A94168773BCD",
    "patient_ID": "TCGA.56.A4BW",
    "bcr_drug_barcode": "TCGA-56-A4BW-D66150",
    "bcr_drug_uuid": "3F4BD48C-57B8-48E2-980B-1A6E59A4A5E1",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B838706D-01E9-45AA-869D-A94168773BCD",
    "patient_ID": "TCGA.56.A4BW",
    "bcr_drug_barcode": "TCGA-56-A4BW-D66151",
    "bcr_drug_uuid": "17CD76AD-14BA-4A0D-96B8-9A17DF1A2DD0",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FD8A7339-CF34-4B91-BFC4-53CE60FFD737",
    "patient_ID": "TCGA.56.A4BX",
    "bcr_drug_barcode": "TCGA-56-A4BX-D60127",
    "bcr_drug_uuid": "9EB3A4C7-2D0D-4396-A2FC-692A28F3F93D",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "CHEMO, NOS",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76618CF5-F6E0-46EF-A1C0-ACC0AD9FDCCB",
    "patient_ID": "TCGA.56.A62T",
    "bcr_drug_barcode": "TCGA-56-A62T-D66647",
    "bcr_drug_uuid": "50B6136D-E914-4F39-A21B-B8E86FD9B857",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "76618CF5-F6E0-46EF-A1C0-ACC0AD9FDCCB",
    "patient_ID": "TCGA.56.A62T",
    "bcr_drug_barcode": "TCGA-56-A62T-D66649",
    "bcr_drug_uuid": "82A53D0A-6350-4C14-B725-327C2712E631",
    "form_completion_date": "2014-10-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b599ce3-6aed-4333-8ba5-2b1bf7ec7aab",
    "patient_ID": "TCGA.58.8387",
    "bcr_drug_barcode": "TCGA-58-8387-D33510",
    "bcr_drug_uuid": "C67727C3-E4F0-42B1-A5A2-3474F4067DF3",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7b599ce3-6aed-4333-8ba5-2b1bf7ec7aab",
    "patient_ID": "TCGA.58.8387",
    "bcr_drug_barcode": "TCGA-58-8387-D43185",
    "bcr_drug_uuid": "BEE41A26-4D5D-4424-A41B-74F3E322A6BE",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9ed5c6fe-24d2-4ee6-88ba-7319c9cfa05e",
    "patient_ID": "TCGA.58.8391",
    "bcr_drug_barcode": "TCGA-58-8391-D33508",
    "bcr_drug_uuid": "D396FA38-F109-437C-A734-0DC2B8CA8671",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9ed5c6fe-24d2-4ee6-88ba-7319c9cfa05e",
    "patient_ID": "TCGA.58.8391",
    "bcr_drug_barcode": "TCGA-58-8391-D43186",
    "bcr_drug_uuid": "D7B49C5C-2F64-405A-A2DF-2BE0A9B8E4AF",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DFF43217-7857-42CA-B87B-058C774A6AA7",
    "patient_ID": "TCGA.58.A46J",
    "bcr_drug_barcode": "TCGA-58-A46J-D36301",
    "bcr_drug_uuid": "6C2CAE90-6334-40CE-8611-C9AE3E9E13CE",
    "form_completion_date": "2012-10-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DFF43217-7857-42CA-B87B-058C774A6AA7",
    "patient_ID": "TCGA.58.A46J",
    "bcr_drug_barcode": "TCGA-58-A46J-D43187",
    "bcr_drug_uuid": "197C1200-584D-49C7-A0F8-8C9FAFBD8C30",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D8D53DF1-42D6-4D8B-AC4C-6F3993AC247D",
    "patient_ID": "TCGA.58.A46K",
    "bcr_drug_barcode": "TCGA-58-A46K-D36299",
    "bcr_drug_uuid": "ED901B75-674E-4DBB-9B5C-A18B119786FB",
    "form_completion_date": "2012-10-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D8D53DF1-42D6-4D8B-AC4C-6F3993AC247D",
    "patient_ID": "TCGA.58.A46K",
    "bcr_drug_barcode": "TCGA-58-A46K-D43188",
    "bcr_drug_uuid": "8727FFB4-B037-4F3F-9F88-07E3BCF88F89",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1BA4E70C-692C-487A-ABC5-36E5F0A03286",
    "patient_ID": "TCGA.58.A46L",
    "bcr_drug_barcode": "TCGA-58-A46L-D36302",
    "bcr_drug_uuid": "7B4811EB-B63E-4DBB-9685-EEED68622451",
    "form_completion_date": "2012-10-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1BA4E70C-692C-487A-ABC5-36E5F0A03286",
    "patient_ID": "TCGA.58.A46L",
    "bcr_drug_barcode": "TCGA-58-A46L-D43189",
    "bcr_drug_uuid": "DE8F4EF3-7870-48C0-B0EC-5C9ED9715C21",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20967",
    "bcr_drug_uuid": "22030067-fab7-4608-9a85-3822702203ba",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20969",
    "bcr_drug_uuid": "e9590cd6-c041-4463-901c-afa656b4c8d0",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CCNU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20970",
    "bcr_drug_uuid": "d728e52c-8ff9-4171-9673-3ee8a26e97c3",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20971",
    "bcr_drug_uuid": "0267fdea-1e47-452a-b5fb-3c1ec0f97cad",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20972",
    "bcr_drug_uuid": "0d91deb4-c24b-48fb-b6f5-69f4e5504073",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20973",
    "bcr_drug_uuid": "a48dea40-75b7-4de6-b8fd-6e754472ebcc",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 351,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 200,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "3c112114-6a8b-4aea-9349-6dffbaad078d",
    "patient_ID": "TCGA.60.2697",
    "bcr_drug_barcode": "TCGA-60-2697-D20974",
    "bcr_drug_uuid": "01dcf723-9620-4410-bac3-d91032cc0f21",
    "form_completion_date": "2012-1-19",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 351,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "fd9ee494-65fe-4de4-adff-7952a059b17f",
    "patient_ID": "TCGA.60.2698",
    "bcr_drug_barcode": "TCGA-60-2698-D17934",
    "bcr_drug_uuid": "810dd93a-0a5a-4745-95df-3032fba5e863",
    "form_completion_date": "2010-7-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 180,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "fd9ee494-65fe-4de4-adff-7952a059b17f",
    "patient_ID": "TCGA.60.2698",
    "bcr_drug_barcode": "TCGA-60-2698-D5383",
    "bcr_drug_uuid": "8467bd1b-4055-46a4-ae49-053fda378041",
    "form_completion_date": "2010-7-26",
    "pharmaceutical_therapy_drug_name": "MITHRAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 180,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "fd9ee494-65fe-4de4-adff-7952a059b17f",
    "patient_ID": "TCGA.60.2698",
    "bcr_drug_barcode": "TCGA-60-2698-D17933",
    "bcr_drug_uuid": "9ff048ee-8623-4523-b58f-a27b61adff88",
    "form_completion_date": "2010-7-26",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 180,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "469eba45-5046-4d8a-9f9a-dfbd1e7cf560",
    "patient_ID": "TCGA.60.2704",
    "bcr_drug_barcode": "TCGA-60-2704-D20236",
    "bcr_drug_uuid": "b0a45e50-dcce-4859-a436-27a4057a400e",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1073,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1093,
    "drug_cycles": 3,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "469eba45-5046-4d8a-9f9a-dfbd1e7cf560",
    "patient_ID": "TCGA.60.2704",
    "bcr_drug_barcode": "TCGA-60-2704-D20235",
    "bcr_drug_uuid": "c917c833-d44d-4c32-a68b-bc1cfcc39e70",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 712,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "469eba45-5046-4d8a-9f9a-dfbd1e7cf560",
    "patient_ID": "TCGA.60.2704",
    "bcr_drug_barcode": "TCGA-60-2704-D20228",
    "bcr_drug_uuid": "371d4a44-17e0-4d2b-9acd-8e63352afeb1",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 712,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "469eba45-5046-4d8a-9f9a-dfbd1e7cf560",
    "patient_ID": "TCGA.60.2704",
    "bcr_drug_barcode": "TCGA-60-2704-D20237",
    "bcr_drug_uuid": "6187e349-27ba-452b-8186-68f99cf5302a",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1073,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1093,
    "drug_cycles": 3,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4d687740-96ca-4d78-8c78-1a2024ce6b6c",
    "patient_ID": "TCGA.60.2707",
    "bcr_drug_barcode": "TCGA-60-2707-D5392",
    "bcr_drug_uuid": "9c22fb76-8aa0-401f-b83c-c5b52bc90e5a",
    "form_completion_date": "2010-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 587,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 594,
    "drug_cycles": 2,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2ca47049-bc12-4992-b9cf-1c01dda639be",
    "patient_ID": "TCGA.60.2708",
    "bcr_drug_barcode": "TCGA-60-2708-D17935",
    "bcr_drug_uuid": "43201dbf-fbae-4a44-82fd-a5eddf5104fd",
    "form_completion_date": "2010-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2ca47049-bc12-4992-b9cf-1c01dda639be",
    "patient_ID": "TCGA.60.2708",
    "bcr_drug_barcode": "TCGA-60-2708-D5394",
    "bcr_drug_uuid": "1cbc3714-f968-4908-894f-d19f4b831696",
    "form_completion_date": "2010-7-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 4,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b28e3be1-9843-4204-b999-b3e2a909c7bd",
    "patient_ID": "TCGA.60.2710",
    "bcr_drug_barcode": "TCGA-60-2710-D5396",
    "bcr_drug_uuid": "0e32fdc8-3ebb-4ab5-a71b-a6a855d3e62b",
    "form_completion_date": "2010-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b28e3be1-9843-4204-b999-b3e2a909c7bd",
    "patient_ID": "TCGA.60.2710",
    "bcr_drug_barcode": "TCGA-60-2710-D13276",
    "bcr_drug_uuid": "59e6c7ae-f010-4bc2-85b2-e95db499bc3a",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 500,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "b28e3be1-9843-4204-b999-b3e2a909c7bd",
    "patient_ID": "TCGA.60.2710",
    "bcr_drug_barcode": "TCGA-60-2710-D13355",
    "bcr_drug_uuid": "f1b05e4b-4472-4b8f-8861-1cde4fdf79e2",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "b28e3be1-9843-4204-b999-b3e2a909c7bd",
    "patient_ID": "TCGA.60.2710",
    "bcr_drug_barcode": "TCGA-60-2710-D13278",
    "bcr_drug_uuid": "8d383d77-c043-439f-b7a3-9d479d9df810",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "PREMETREXED",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 500,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "e58e8850-154f-4695-bee0-005c76410327",
    "patient_ID": "TCGA.60.2713",
    "bcr_drug_barcode": "TCGA-60-2713-D13271",
    "bcr_drug_uuid": "5bd01b78-6d3b-4fa4-8fef-fe9d995e3899",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1731,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8950
  },
  {
    "bcr_patient_uuid": "e58e8850-154f-4695-bee0-005c76410327",
    "patient_ID": "TCGA.60.2713",
    "bcr_drug_barcode": "TCGA-60-2713-D13272",
    "bcr_drug_uuid": "e6cf7d1e-e7c2-4209-94e3-c2db0a689f90",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1611,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1731,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 895
  },
  {
    "bcr_patient_uuid": "705a4688-f10f-4e6a-aed9-6efc3b3b9989",
    "patient_ID": "TCGA.60.2714",
    "bcr_drug_barcode": "TCGA-60-2714-D13262",
    "bcr_drug_uuid": "13f56d70-bd0a-4556-bab5-15b1b2a6c67e",
    "form_completion_date": "2011-6-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 350,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "705a4688-f10f-4e6a-aed9-6efc3b3b9989",
    "patient_ID": "TCGA.60.2714",
    "bcr_drug_barcode": "TCGA-60-2714-D13263",
    "bcr_drug_uuid": "aa4f6375-fb08-4c6a-a58d-bc71b628e798",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 217,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "705a4688-f10f-4e6a-aed9-6efc3b3b9989",
    "patient_ID": "TCGA.60.2714",
    "bcr_drug_barcode": "TCGA-60-2714-D13260",
    "bcr_drug_uuid": "37692bdf-2f6d-44bb-9972-ba74addf62d1",
    "form_completion_date": "2011-6-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEO-ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12852",
    "bcr_drug_uuid": "c3e9cd2d-f5f7-45b6-8449-42b2492d3e7d",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "TL32711",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 903,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 955,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 4.78,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 26.68
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12850",
    "bcr_drug_uuid": "142c582f-88a3-411f-b740-876315e521bb",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 633,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1770,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12849",
    "bcr_drug_uuid": "15f48b3b-eb35-4a14-8aee-849b276b972b",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 546,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 633,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 551,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2204
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12851",
    "bcr_drug_uuid": "4d05a9e1-9474-4fa8-849e-97441a16f303",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 643,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 766,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 19500
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12845",
    "bcr_drug_uuid": "0c10aa80-123e-4886-b094-f2db6f5905ce",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12847",
    "bcr_drug_uuid": "5263e9ff-89ac-4445-acef-33e85e725508",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 773,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 794,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 25,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "f3e67161-1532-4b50-a9b5-0da80410c4d7",
    "patient_ID": "TCGA.60.2715",
    "bcr_drug_barcode": "TCGA-60-2715-D12846",
    "bcr_drug_uuid": "8b537cec-a794-42bc-b09d-e059588ca14e",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 448,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 511,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "7e691df8-8ea6-472c-86bf-504c7ba6983d",
    "patient_ID": "TCGA.60.2716",
    "bcr_drug_barcode": "TCGA-60-2716-D5402",
    "bcr_drug_uuid": "eda960de-0c4a-4bd9-b6b5-bda5f45eb41f",
    "form_completion_date": "2010-7-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_dose": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 24
  },
  {
    "bcr_patient_uuid": "7e691df8-8ea6-472c-86bf-504c7ba6983d",
    "patient_ID": "TCGA.60.2716",
    "bcr_drug_barcode": "TCGA-60-2716-D13258",
    "bcr_drug_uuid": "3cd2a707-ad29-40fc-b093-2931c501c959",
    "form_completion_date": "2011-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 270
  },
  {
    "bcr_patient_uuid": "7e691df8-8ea6-472c-86bf-504c7ba6983d",
    "patient_ID": "TCGA.60.2716",
    "bcr_drug_barcode": "TCGA-60-2716-D13257",
    "bcr_drug_uuid": "0699488e-d573-403e-a758-f4339249f7d0",
    "form_completion_date": "2011-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 200,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "337e77b3-7f58-4f92-96a4-c764b1ebfa56",
    "patient_ID": "TCGA.60.2720",
    "bcr_drug_barcode": "TCGA-60-2720-D5406",
    "bcr_drug_uuid": "2c1ad5d7-16af-49ea-a145-bf3a16592d8f",
    "form_completion_date": "2010-7-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 1,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "337e77b3-7f58-4f92-96a4-c764b1ebfa56",
    "patient_ID": "TCGA.60.2720",
    "bcr_drug_barcode": "TCGA-60-2720-D13096",
    "bcr_drug_uuid": "c7d798fe-24fa-4d06-b4d7-16883f51eec8",
    "form_completion_date": "2011-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6fd72426-f6c8-47ca-a500-d5d3600b9b15",
    "patient_ID": "TCGA.60.2722",
    "bcr_drug_barcode": "TCGA-60-2722-D5409",
    "bcr_drug_uuid": "4e0964e9-d67d-4226-a2df-f73b5658521c",
    "form_completion_date": "2010-7-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 450,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2700
  },
  {
    "bcr_patient_uuid": "6fd72426-f6c8-47ca-a500-d5d3600b9b15",
    "patient_ID": "TCGA.60.2722",
    "bcr_drug_barcode": "TCGA-60-2722-D13250",
    "bcr_drug_uuid": "5f958a71-c3bd-4e55-9f17-476c26e3b425",
    "form_completion_date": "2011-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1080
  },
  {
    "bcr_patient_uuid": "a3e1ac67-a1f2-44fb-8343-a7e8239fc24a",
    "patient_ID": "TCGA.60.2724",
    "bcr_drug_barcode": "TCGA-60-2724-D5412",
    "bcr_drug_uuid": "d66d5585-e794-44ea-a7a8-3b569c810832",
    "form_completion_date": "2010-7-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a3e1ac67-a1f2-44fb-8343-a7e8239fc24a",
    "patient_ID": "TCGA.60.2724",
    "bcr_drug_barcode": "TCGA-60-2724-D7015",
    "bcr_drug_uuid": "55328ac7-4aa4-429a-aabd-f5203475bc74",
    "form_completion_date": "2010-7-20",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "31d8591b-9d80-406c-b61a-7a6544c73466",
    "patient_ID": "TCGA.63.7023",
    "bcr_drug_barcode": "TCGA-63-7023-D17910",
    "bcr_drug_uuid": "da0c0701-a079-4d70-b2b1-a06b1a965177",
    "form_completion_date": "2011-10-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 92,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 184
  },
  {
    "bcr_patient_uuid": "31d8591b-9d80-406c-b61a-7a6544c73466",
    "patient_ID": "TCGA.63.7023",
    "bcr_drug_barcode": "TCGA-63-7023-D17909",
    "bcr_drug_uuid": "4a2d25dd-d159-4bbd-b13f-b011d6031661",
    "form_completion_date": "2011-10-14",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 46,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 92
  },
  {
    "bcr_patient_uuid": "9B07EF0C-1329-4341-A5A4-42ABE7A6737C",
    "patient_ID": "TCGA.63.A5MB",
    "bcr_drug_barcode": "TCGA-63-A5MB-D48797",
    "bcr_drug_uuid": "6869D81C-A955-4790-9D6E-AE38287B5EC4",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9B07EF0C-1329-4341-A5A4-42ABE7A6737C",
    "patient_ID": "TCGA.63.A5MB",
    "bcr_drug_barcode": "TCGA-63-A5MB-D48798",
    "bcr_drug_uuid": "43DD00B3-85DD-4489-A6B7-16D95D380242",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A02B991-39F7-4C52-9F6E-BF0F7C7BDE8D",
    "patient_ID": "TCGA.63.A5MI",
    "bcr_drug_barcode": "TCGA-63-A5MI-D48822",
    "bcr_drug_uuid": "F1F3F2B4-AD01-421D-B81D-A0366253E958",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A02B991-39F7-4C52-9F6E-BF0F7C7BDE8D",
    "patient_ID": "TCGA.63.A5MI",
    "bcr_drug_barcode": "TCGA-63-A5MI-D48823",
    "bcr_drug_uuid": "4C0DFC88-3A53-4D42-8575-85210FC03C7E",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1A02B991-39F7-4C52-9F6E-BF0F7C7BDE8D",
    "patient_ID": "TCGA.63.A5MI",
    "bcr_drug_barcode": "TCGA-63-A5MI-D48824",
    "bcr_drug_uuid": "04ADE337-F42D-4CCE-A82C-0176FE0A853D",
    "form_completion_date": "2013-9-24",
    "clinical_trial_drug_classification": "MAGE/A3",
    "pharmaceutical_therapy_type": "VACCINE",
    "days_to_drug_start": 182,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 945,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "63D2A48D-50EC-4E84-86E7-C4B74C49D08F",
    "patient_ID": "TCGA.63.A5MJ",
    "bcr_drug_barcode": "TCGA-63-A5MJ-D48827",
    "bcr_drug_uuid": "0175EB00-5C44-4D7D-BA08-45F7AB484FF3",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "63D2A48D-50EC-4E84-86E7-C4B74C49D08F",
    "patient_ID": "TCGA.63.A5MJ",
    "bcr_drug_barcode": "TCGA-63-A5MJ-D48828",
    "bcr_drug_uuid": "48738FB4-F5BC-4E8C-9BF7-15EECE7CA5B2",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "63D2A48D-50EC-4E84-86E7-C4B74C49D08F",
    "patient_ID": "TCGA.63.A5MJ",
    "bcr_drug_barcode": "TCGA-63-A5MJ-D48829",
    "bcr_drug_uuid": "1B6A26FB-090F-4155-BBA9-B07DA8656295",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DDF19EB8-C3FE-441E-B6CF-C4943B6789D9",
    "patient_ID": "TCGA.63.A5ML",
    "bcr_drug_barcode": "TCGA-63-A5ML-D48835",
    "bcr_drug_uuid": "974AFD1E-6091-4BEE-9F89-C88641F793AB",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DDF19EB8-C3FE-441E-B6CF-C4943B6789D9",
    "patient_ID": "TCGA.63.A5ML",
    "bcr_drug_barcode": "TCGA-63-A5ML-D48836",
    "bcr_drug_uuid": "E7C424AF-F7A3-4517-8F52-097FA19AB665",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ABC753F0-5AE2-4BEC-96B8-6A05D84BF1C1",
    "patient_ID": "TCGA.63.A5MM",
    "bcr_drug_barcode": "TCGA-63-A5MM-D48877",
    "bcr_drug_uuid": "8A15EA6C-7D7A-471E-9BD7-A0A370C4DA3C",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 58,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "ABC753F0-5AE2-4BEC-96B8-6A05D84BF1C1",
    "patient_ID": "TCGA.63.A5MM",
    "bcr_drug_barcode": "TCGA-63-A5MM-D48878",
    "bcr_drug_uuid": "5677E515-5B24-473A-8C50-9C830848B573",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 58,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F18C47E1-516F-43F7-8D31-4E5012BD22F0",
    "patient_ID": "TCGA.63.A5MP",
    "bcr_drug_barcode": "TCGA-63-A5MP-D48887",
    "bcr_drug_uuid": "FF5FE443-3B48-4E7A-AD00-6323801D9180",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F18C47E1-516F-43F7-8D31-4E5012BD22F0",
    "patient_ID": "TCGA.63.A5MP",
    "bcr_drug_barcode": "TCGA-63-A5MP-D48889",
    "bcr_drug_uuid": "27211782-6D40-494B-9FBC-569489ADA69E",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "531D1248-76AE-46A1-8F65-CDECF9BCB0D8",
    "patient_ID": "TCGA.63.A5MT",
    "bcr_drug_barcode": "TCGA-63-A5MT-D48951",
    "bcr_drug_uuid": "0A37CAF3-F5EF-419D-8B97-C7AF3E4D2213",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "531D1248-76AE-46A1-8F65-CDECF9BCB0D8",
    "patient_ID": "TCGA.63.A5MT",
    "bcr_drug_barcode": "TCGA-63-A5MT-D48953",
    "bcr_drug_uuid": "21DCEECB-5E90-4FBD-9EC6-DB44EAC875BF",
    "form_completion_date": "2013-9-24",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 124,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7625A27D-A012-4F4D-B637-5F85D7CDAE8C",
    "patient_ID": "TCGA.63.A5MU",
    "bcr_drug_barcode": "TCGA-63-A5MU-D49015",
    "bcr_drug_uuid": "3C59FD5B-500D-4511-B838-F5DA03A3B589",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7625A27D-A012-4F4D-B637-5F85D7CDAE8C",
    "patient_ID": "TCGA.63.A5MU",
    "bcr_drug_barcode": "TCGA-63-A5MU-D49016",
    "bcr_drug_uuid": "D2583D78-C731-4ECE-8047-233B7C93942F",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "VINORELBIN TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8D18E026-668B-4513-9C68-9E03B18592E3",
    "patient_ID": "TCGA.63.A5MV",
    "bcr_drug_barcode": "TCGA-63-A5MV-D49022",
    "bcr_drug_uuid": "6DDCA169-7596-4802-A69B-8BB97D496877",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8D18E026-668B-4513-9C68-9E03B18592E3",
    "patient_ID": "TCGA.63.A5MV",
    "bcr_drug_barcode": "TCGA-63-A5MV-D49024",
    "bcr_drug_uuid": "811D87FD-37DD-4142-9AB4-E1A816595858",
    "form_completion_date": "2013-9-25",
    "pharmaceutical_therapy_drug_name": "VINORELBINE TARTRATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a02932f3-5606-42a5-aee4-e5b9f5aa1aaa",
    "patient_ID": "TCGA.66.2757",
    "bcr_drug_barcode": "TCGA-66-2757-D36957",
    "bcr_drug_uuid": "8150705F-2447-445D-8D04-327BFDE4D292",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 943,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1035,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a02932f3-5606-42a5-aee4-e5b9f5aa1aaa",
    "patient_ID": "TCGA.66.2757",
    "bcr_drug_barcode": "TCGA-66-2757-D36958",
    "bcr_drug_uuid": "06901047-8E23-4FD5-94F9-FA9BC6E65805",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 943,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 943,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a02932f3-5606-42a5-aee4-e5b9f5aa1aaa",
    "patient_ID": "TCGA.66.2757",
    "bcr_drug_barcode": "TCGA-66-2757-D36961",
    "bcr_drug_uuid": "632C27CA-AEE1-4CA5-BFA0-60EF8D1C5C84",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1277,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dca4c540-897f-435b-9ee2-8f5b2e8734c6",
    "patient_ID": "TCGA.66.2758",
    "bcr_drug_barcode": "TCGA-66-2758-D36609",
    "bcr_drug_uuid": "FB434B10-9AF4-477A-87BE-3F2E6190DCC9",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dca4c540-897f-435b-9ee2-8f5b2e8734c6",
    "patient_ID": "TCGA.66.2758",
    "bcr_drug_barcode": "TCGA-66-2758-D36610",
    "bcr_drug_uuid": "AD2ED244-0961-46E7-90A6-ADEECFC10CC5",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e6b72c24-1607-43b9-8b8a-7bf83eea5895",
    "patient_ID": "TCGA.66.2759",
    "bcr_drug_barcode": "TCGA-66-2759-D36688",
    "bcr_drug_uuid": "D1D0716E-9968-45D0-B496-A18C951556B1",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "e6b72c24-1607-43b9-8b8a-7bf83eea5895",
    "patient_ID": "TCGA.66.2759",
    "bcr_drug_barcode": "TCGA-66-2759-D36689",
    "bcr_drug_uuid": "3E28237C-3389-48E1-B3B6-4F4B3540FCA9",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1535c8ab-100d-4886-8598-12a94483d010",
    "patient_ID": "TCGA.66.2771",
    "bcr_drug_barcode": "TCGA-66-2771-D36694",
    "bcr_drug_uuid": "6E11FED7-4213-41C7-985E-3ACBE3485ADC",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1535c8ab-100d-4886-8598-12a94483d010",
    "patient_ID": "TCGA.66.2771",
    "bcr_drug_barcode": "TCGA-66-2771-D37690",
    "bcr_drug_uuid": "1EC683CB-84BA-442A-A4A4-9B42100E6D70",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "aabc43bb-485a-49bc-b48a-d4e4ecd46d33",
    "patient_ID": "TCGA.66.2778",
    "bcr_drug_barcode": "TCGA-66-2778-D36697",
    "bcr_drug_uuid": "4A91E26E-05E4-40EA-BD97-015BC02EF14E",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "aabc43bb-485a-49bc-b48a-d4e4ecd46d33",
    "patient_ID": "TCGA.66.2778",
    "bcr_drug_barcode": "TCGA-66-2778-D37691",
    "bcr_drug_uuid": "25859CDE-2F5C-465E-BFC5-E24B4E89071A",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "90b02be3-5496-40a2-8c6e-460d2898aadb",
    "patient_ID": "TCGA.66.2782",
    "bcr_drug_barcode": "TCGA-66-2782-D37033",
    "bcr_drug_uuid": "C9F01FD8-7969-4CEA-A67B-E8D48D90DCC7",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY"
  },
  {
    "bcr_patient_uuid": "d5e14ef5-1b78-4498-a2e2-77070c83eb7f",
    "patient_ID": "TCGA.66.2783",
    "bcr_drug_barcode": "TCGA-66-2783-D37020",
    "bcr_drug_uuid": "F88F25B1-5D5F-4DF4-981A-BAD29D73B159",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d5e14ef5-1b78-4498-a2e2-77070c83eb7f",
    "patient_ID": "TCGA.66.2783",
    "bcr_drug_barcode": "TCGA-66-2783-D37021",
    "bcr_drug_uuid": "04ED6633-DA37-4D3A-AEAD-F3C4749A1F95",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ede3e359-bc49-4899-abe5-92dc65588286",
    "patient_ID": "TCGA.66.2790",
    "bcr_drug_barcode": "TCGA-66-2790-D37039",
    "bcr_drug_uuid": "9BE5B640-E7B7-4ED2-94AC-C31B479F123D",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "treatment_best_response": "PROGRESSIVE DISEASE"
  },
  {
    "bcr_patient_uuid": "40dc2edc-4bde-441d-8fc5-8ce1bd42f267",
    "patient_ID": "TCGA.66.2792",
    "bcr_drug_barcode": "TCGA-66-2792-D37043",
    "bcr_drug_uuid": "8B4C2FB0-E0D3-46D2-972B-F1F822FAB353",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "40dc2edc-4bde-441d-8fc5-8ce1bd42f267",
    "patient_ID": "TCGA.66.2792",
    "bcr_drug_barcode": "TCGA-66-2792-D37045",
    "bcr_drug_uuid": "49524870-5409-439A-A9FA-84F2D3A6B8EE",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3666bc65-8e40-409e-9a1f-41583dd6d978",
    "patient_ID": "TCGA.68.7755",
    "bcr_drug_barcode": "TCGA-68-7755-D20818",
    "bcr_drug_uuid": "a00f2923-c38e-4a45-b798-7edb05ab0a1d",
    "form_completion_date": "2012-1-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c6debfbb-de60-4d0d-aec2-d8d514c1f313",
    "patient_ID": "TCGA.68.7756",
    "bcr_drug_barcode": "TCGA-68-7756-D20880",
    "bcr_drug_uuid": "368f3639-a1ca-4eaa-a925-b49a70d58e6a",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d484c95f-5128-4239-a6e5-1496de39ba4b",
    "patient_ID": "TCGA.68.8251",
    "bcr_drug_barcode": "TCGA-68-8251-D32381",
    "bcr_drug_uuid": "18F0D2CE-7261-4D43-9D54-F7BE3A16C703",
    "form_completion_date": "2012-5-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "d484c95f-5128-4239-a6e5-1496de39ba4b",
    "patient_ID": "TCGA.68.8251",
    "bcr_drug_barcode": "TCGA-68-8251-D32382",
    "bcr_drug_uuid": "CEE26805-572A-4EDE-9766-A285F76E7E0F",
    "form_completion_date": "2012-5-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0F8A76A1-4C3E-42E1-9DF3-95AA3AE8E676",
    "patient_ID": "TCGA.68.A59I",
    "bcr_drug_barcode": "TCGA-68-A59I-D40352",
    "bcr_drug_uuid": "52984027-6AAD-4999-96CD-AE6DF723295E",
    "form_completion_date": "2013-2-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0F8A76A1-4C3E-42E1-9DF3-95AA3AE8E676",
    "patient_ID": "TCGA.68.A59I",
    "bcr_drug_barcode": "TCGA-68-A59I-D40351",
    "bcr_drug_uuid": "E9B37E36-0BDA-4513-8128-98E9B366BA08",
    "form_completion_date": "2013-2-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0F8A76A1-4C3E-42E1-9DF3-95AA3AE8E676",
    "patient_ID": "TCGA.68.A59I",
    "bcr_drug_barcode": "TCGA-68-A59I-D56683",
    "bcr_drug_uuid": "638F5B86-FB1A-4D5E-B4FD-BB53AFCDD685",
    "form_completion_date": "2014-2-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0F8A76A1-4C3E-42E1-9DF3-95AA3AE8E676",
    "patient_ID": "TCGA.68.A59I",
    "bcr_drug_barcode": "TCGA-68-A59I-D56685",
    "bcr_drug_uuid": "C0921151-EF45-418A-A7B4-842E0384A1D2",
    "form_completion_date": "2014-2-18",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 216,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "870fb708-7631-4578-a470-3c7bd5228e5a",
    "patient_ID": "TCGA.85.6560",
    "bcr_drug_barcode": "TCGA-85-6560-D29743",
    "bcr_drug_uuid": "3B8629A0-BFB0-49E0-958E-B3B38C1B68F1",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "870fb708-7631-4578-a470-3c7bd5228e5a",
    "patient_ID": "TCGA.85.6560",
    "bcr_drug_barcode": "TCGA-85-6560-D29739",
    "bcr_drug_uuid": "BC8BC803-D477-4F01-8545-2829D8C497AB",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 840
  },
  {
    "bcr_patient_uuid": "46f35964-bd43-47e6-83fe-40da33828c94",
    "patient_ID": "TCGA.85.6561",
    "bcr_drug_barcode": "TCGA-85-6561-D29754",
    "bcr_drug_uuid": "64EC512E-75AF-454A-BF28-553FC932F40B",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "46f35964-bd43-47e6-83fe-40da33828c94",
    "patient_ID": "TCGA.85.6561",
    "bcr_drug_barcode": "TCGA-85-6561-D29758",
    "bcr_drug_uuid": "F92C726B-E8E5-4E30-B25E-9DA6130DC050",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 45,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "46f35964-bd43-47e6-83fe-40da33828c94",
    "patient_ID": "TCGA.85.6561",
    "bcr_drug_barcode": "TCGA-85-6561-D29756",
    "bcr_drug_uuid": "77616329-74BD-4A0F-9D23-ED5E1D5C6B2C",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "46f35964-bd43-47e6-83fe-40da33828c94",
    "patient_ID": "TCGA.85.6561",
    "bcr_drug_barcode": "TCGA-85-6561-D29752",
    "bcr_drug_uuid": "FC912923-CC60-4F1E-A282-1653A606216A",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 5,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG",
    "drug_dose": 75,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "59b006b0-4a81-41c8-9574-29a732428e29",
    "patient_ID": "TCGA.85.6798",
    "bcr_drug_barcode": "TCGA-85-6798-D65761",
    "bcr_drug_uuid": "54CFBC9C-1CE5-48CB-AF2C-BA40C865A955",
    "form_completion_date": "2014-9-30",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "59b006b0-4a81-41c8-9574-29a732428e29",
    "patient_ID": "TCGA.85.6798",
    "bcr_drug_barcode": "TCGA-85-6798-D65762",
    "bcr_drug_uuid": "9847173A-B627-4B19-9509-7E9018945AE2",
    "form_completion_date": "2014-9-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "caa36b5c-852b-4259-8db9-1091b1f02edd",
    "patient_ID": "TCGA.85.7697",
    "bcr_drug_barcode": "TCGA-85-7697-D65977",
    "bcr_drug_uuid": "2C853E6E-B369-4F47-9B35-DDBFD7D3F88C",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "caa36b5c-852b-4259-8db9-1091b1f02edd",
    "patient_ID": "TCGA.85.7697",
    "bcr_drug_barcode": "TCGA-85-7697-D65981",
    "bcr_drug_uuid": "304D5C10-FA28-4FE0-8018-3087DE3778F6",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a13a742-ff9a-4432-a7ce-7fcbb753be01",
    "patient_ID": "TCGA.85.7698",
    "bcr_drug_barcode": "TCGA-85-7698-D65985",
    "bcr_drug_uuid": "9B2D4976-4124-4BAF-99DC-D9E346A88C23",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 654,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 738,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9a13a742-ff9a-4432-a7ce-7fcbb753be01",
    "patient_ID": "TCGA.85.7698",
    "bcr_drug_barcode": "TCGA-85-7698-D65986",
    "bcr_drug_uuid": "AC75D5D0-13D6-43A8-AD8E-0F86909A12AE",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 654,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 738,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06f36fce-f20f-4e37-8222-81a642c7bba0",
    "patient_ID": "TCGA.85.7699",
    "bcr_drug_barcode": "TCGA-85-7699-D65988",
    "bcr_drug_uuid": "C5B86771-0225-43B8-A38B-07F4476CF8BA",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06f36fce-f20f-4e37-8222-81a642c7bba0",
    "patient_ID": "TCGA.85.7699",
    "bcr_drug_barcode": "TCGA-85-7699-D65989",
    "bcr_drug_uuid": "31E60E49-2696-45D2-9142-27F0F6B12C1B",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06f36fce-f20f-4e37-8222-81a642c7bba0",
    "patient_ID": "TCGA.85.7699",
    "bcr_drug_barcode": "TCGA-85-7699-D65990",
    "bcr_drug_uuid": "C7DDE231-C2CD-4D83-8011-14051DCB9200",
    "form_completion_date": "2014-10-15",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 761,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 892,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06f36fce-f20f-4e37-8222-81a642c7bba0",
    "patient_ID": "TCGA.85.7699",
    "bcr_drug_barcode": "TCGA-85-7699-D65991",
    "bcr_drug_uuid": "2AA02746-0F03-4F74-85F9-848B1BAE59D8",
    "form_completion_date": "2014-10-15",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 761,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 892,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "aef2cf2f-2067-4d77-9bbe-0f6801826c31",
    "patient_ID": "TCGA.85.8276",
    "bcr_drug_barcode": "TCGA-85-8276-D66444",
    "bcr_drug_uuid": "5212C6B2-22B2-4F80-9828-CC425F0D39F0",
    "form_completion_date": "2014-10-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "aef2cf2f-2067-4d77-9bbe-0f6801826c31",
    "patient_ID": "TCGA.85.8276",
    "bcr_drug_barcode": "TCGA-85-8276-D66445",
    "bcr_drug_uuid": "BD77EDB6-F9A9-4DAC-8BFC-002ECD9B6E61",
    "form_completion_date": "2014-10-15",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "aef2cf2f-2067-4d77-9bbe-0f6801826c31",
    "patient_ID": "TCGA.85.8276",
    "bcr_drug_barcode": "TCGA-85-8276-D66446",
    "bcr_drug_uuid": "E8165FA2-AFD5-41EF-B676-82FF50AEAD6A",
    "form_completion_date": "2014-10-15",
    "pharmaceutical_therapy_drug_name": "ZOLEDRONIC ACID",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 1050,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c935a05d-0bd5-4fad-8e06-950afe022bca",
    "patient_ID": "TCGA.85.8351",
    "bcr_drug_barcode": "TCGA-85-8351-D66074",
    "bcr_drug_uuid": "9907C02C-313D-40A2-BF00-FE19C6F89C65",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "c935a05d-0bd5-4fad-8e06-950afe022bca",
    "patient_ID": "TCGA.85.8351",
    "bcr_drug_barcode": "TCGA-85-8351-D66075",
    "bcr_drug_uuid": "C79704EA-5288-4805-BC86-29704A8BF377",
    "form_completion_date": "2014-10-2",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "f30d81c6-d8d3-4547-b056-3942e390b936",
    "patient_ID": "TCGA.85.8664",
    "bcr_drug_barcode": "TCGA-85-8664-D59090",
    "bcr_drug_uuid": "DE153EA5-3BF1-41BE-8F4D-3673A03D7411",
    "form_completion_date": "2014-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 446,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 495,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "67E92755-396E-4D9A-B737-979EADC743F9",
    "patient_ID": "TCGA.85.A4CN",
    "bcr_drug_barcode": "TCGA-85-A4CN-D57773",
    "bcr_drug_uuid": "0837E71D-2499-4DA2-8DAB-23E743B9868A",
    "form_completion_date": "2014-3-26",
    "pharmaceutical_therapy_drug_name": "ERLOTINIB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "264B3066-B77B-4375-9847-ADCF22DBC438",
    "patient_ID": "TCGA.85.A4JB",
    "bcr_drug_barcode": "TCGA-85-A4JB-D56540",
    "bcr_drug_uuid": "06390140-99D5-462E-837A-395FF172B941",
    "form_completion_date": "2014-2-12",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 447,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4CDAC0CF-6598-4D33-92E6-730FBDC88A61",
    "patient_ID": "TCGA.85.A4JC",
    "bcr_drug_barcode": "TCGA-85-A4JC-D48287",
    "bcr_drug_uuid": "3C7B4A37-3265-4C34-85E6-8B4D6EDEAC35",
    "form_completion_date": "2014-1-10",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A0F8D00-86A0-4C63-A8D5-43BD2E13BD96",
    "patient_ID": "TCGA.85.A50Z",
    "bcr_drug_barcode": "TCGA-85-A50Z-D55528",
    "bcr_drug_uuid": "1D7D4633-F5BD-45B6-B214-EF0A27C07893",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "VEPESID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 42,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A0F8D00-86A0-4C63-A8D5-43BD2E13BD96",
    "patient_ID": "TCGA.85.A50Z",
    "bcr_drug_barcode": "TCGA-85-A50Z-D55529",
    "bcr_drug_uuid": "56D87C17-698F-416E-AFB9-6F64AA9795B2",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 42,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCB6447F-3E4C-44FE-AFC3-100D5DBE9BA2",
    "patient_ID": "TCGA.85.A512",
    "bcr_drug_barcode": "TCGA-85-A512-D55531",
    "bcr_drug_uuid": "EB661580-F6E3-4C8E-955A-7ECDAA5B640D",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "VEPESID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BCB6447F-3E4C-44FE-AFC3-100D5DBE9BA2",
    "patient_ID": "TCGA.85.A512",
    "bcr_drug_barcode": "TCGA-85-A512-D55532",
    "bcr_drug_uuid": "461EC91C-2A55-47FB-9F18-971AA8146FCA",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0e515ab8-99f9-43d9-a621-8fe9ede828ec",
    "patient_ID": "TCGA.90.6837",
    "bcr_drug_barcode": "TCGA-90-6837-D21675",
    "bcr_drug_uuid": "4AE72983-9B20-4A04-9E88-96BA10750974",
    "form_completion_date": "2012-5-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0e515ab8-99f9-43d9-a621-8fe9ede828ec",
    "patient_ID": "TCGA.90.6837",
    "bcr_drug_barcode": "TCGA-90-6837-D46082",
    "bcr_drug_uuid": "D2BA7B68-12F9-4F3E-AA6C-DD6D56AE9402",
    "form_completion_date": "2013-7-31",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "0e515ab8-99f9-43d9-a621-8fe9ede828ec",
    "patient_ID": "TCGA.90.6837",
    "bcr_drug_barcode": "TCGA-90-6837-D46083",
    "bcr_drug_uuid": "7E55BA65-342E-4311-9543-AF88CA4EA762",
    "form_completion_date": "2013-7-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "0e515ab8-99f9-43d9-a621-8fe9ede828ec",
    "patient_ID": "TCGA.90.6837",
    "bcr_drug_barcode": "TCGA-90-6837-D46084",
    "bcr_drug_uuid": "BE6C700F-B51D-419A-9C20-040952F35D5B",
    "form_completion_date": "2013-7-31",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "AA02AA9B-5786-463F-9DB4-A9C20D31DC73",
    "patient_ID": "TCGA.90.A4EE",
    "bcr_drug_barcode": "TCGA-90-A4EE-D41930",
    "bcr_drug_uuid": "AB8EA8EE-28BB-4A3A-A100-9C936CB5D0D9",
    "form_completion_date": "2013-4-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "AA02AA9B-5786-463F-9DB4-A9C20D31DC73",
    "patient_ID": "TCGA.90.A4EE",
    "bcr_drug_barcode": "TCGA-90-A4EE-D41931",
    "bcr_drug_uuid": "11E1680A-9F35-4AED-BBB5-908AA04E6A54",
    "form_completion_date": "2013-4-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "80242454-84B3-4FBA-A64B-7D1714CDECDE",
    "patient_ID": "TCGA.90.A59Q",
    "bcr_drug_barcode": "TCGA-90-A59Q-D45222",
    "bcr_drug_uuid": "57B77654-0CE9-4AFB-9429-10916B74305E",
    "form_completion_date": "2013-7-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "COMPLETE RESPONSE"
  },
  {
    "bcr_patient_uuid": "86b165c2-d0e6-4a4f-84ed-aa95e3133627",
    "patient_ID": "TCGA.92.7340",
    "bcr_drug_barcode": "TCGA-92-7340-D18341",
    "bcr_drug_uuid": "2cae1c93-8a0b-4c07-9cb0-4303eaadbcef",
    "form_completion_date": "2011-11-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 789
  },
  {
    "bcr_patient_uuid": "86b165c2-d0e6-4a4f-84ed-aa95e3133627",
    "patient_ID": "TCGA.92.7340",
    "bcr_drug_barcode": "TCGA-92-7340-D20181",
    "bcr_drug_uuid": "ea0164e9-7f42-4166-b70b-6e0b4669187d",
    "form_completion_date": "2012-1-6",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 398
  },
  {
    "bcr_patient_uuid": "418a004e-d5a9-461b-8764-4b581b6b8223",
    "patient_ID": "TCGA.92.8063",
    "bcr_drug_barcode": "TCGA-92-8063-D32171",
    "bcr_drug_uuid": "7637e6c7-7afb-40de-ae68-773b64fd6df1",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "418a004e-d5a9-461b-8764-4b581b6b8223",
    "patient_ID": "TCGA.92.8063",
    "bcr_drug_barcode": "TCGA-92-8063-D32173",
    "bcr_drug_uuid": "577a2a3a-0bdd-4888-96f3-4ad52554dfee",
    "form_completion_date": "2012-5-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dc6ceece-efaa-4b9d-9e12-d35863d7a902",
    "patient_ID": "TCGA.92.8064",
    "bcr_drug_barcode": "TCGA-92-8064-D32181",
    "bcr_drug_uuid": "1af3120b-5d97-4f4b-9c51-6ff9c27a0bf3",
    "form_completion_date": "2012-6-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "dc6ceece-efaa-4b9d-9e12-d35863d7a902",
    "patient_ID": "TCGA.92.8064",
    "bcr_drug_barcode": "TCGA-92-8064-D32563",
    "bcr_drug_uuid": "817d3f4e-ae3c-4dee-971b-db9b25a278ab",
    "form_completion_date": "2012-6-4",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3351b902-9b7e-4b90-bf6b-bcf74be00bc1",
    "patient_ID": "TCGA.94.7033",
    "bcr_drug_barcode": "TCGA-94-7033-D15663",
    "bcr_drug_uuid": "10b5e96c-bb1a-4749-a606-8bace973465b",
    "form_completion_date": "2011-8-00",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 143,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 143
  },
  {
    "bcr_patient_uuid": "3351b902-9b7e-4b90-bf6b-bcf74be00bc1",
    "patient_ID": "TCGA.94.7033",
    "bcr_drug_barcode": "TCGA-94-7033-D15928",
    "bcr_drug_uuid": "b23ee72a-de31-4436-a58b-ea4e24bb62f7",
    "form_completion_date": "2011-9-00",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 143,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 143
  },
  {
    "bcr_patient_uuid": "3429df57-5aae-41aa-8247-6a2ea935a934",
    "patient_ID": "TCGA.94.8035",
    "bcr_drug_barcode": "TCGA-94-8035-D33086",
    "bcr_drug_uuid": "0F000946-F237-4E94-AFF9-472E36A50BA1",
    "form_completion_date": "2012-6-20",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "aeb67cc2-1573-4782-a6f8-baef7c2c5c47",
    "patient_ID": "TCGA.94.8491",
    "bcr_drug_barcode": "TCGA-94-8491-D58415",
    "bcr_drug_uuid": "B0C517A9-A8B8-4145-8C76-178C58806194",
    "form_completion_date": "2014-4-9",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "644F0C64-C710-4FAA-ADA5-CBB9A52ACF93",
    "patient_ID": "TCGA.94.A5I6",
    "bcr_drug_barcode": "TCGA-94-A5I6-D43025",
    "bcr_drug_uuid": "6402C603-4067-40D5-BDB6-97A1A5A2BC1E",
    "form_completion_date": "2013-5-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "644F0C64-C710-4FAA-ADA5-CBB9A52ACF93",
    "patient_ID": "TCGA.94.A5I6",
    "bcr_drug_barcode": "TCGA-94-A5I6-D43027",
    "bcr_drug_uuid": "377E8829-C682-4D40-9429-11DBFBEB92D0",
    "form_completion_date": "2013-5-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 164,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "613ADBB3-C2D1-4992-9953-C4FADD249001",
    "patient_ID": "TCGA.96.A4JK",
    "bcr_drug_barcode": "TCGA-96-A4JK-D40918",
    "bcr_drug_uuid": "D2ABC2A9-8DF3-43A8-9CF0-CE090BB383E0",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "613ADBB3-C2D1-4992-9953-C4FADD249001",
    "patient_ID": "TCGA.96.A4JK",
    "bcr_drug_barcode": "TCGA-96-A4JK-D40919",
    "bcr_drug_uuid": "FCE82BE2-BAB7-416D-8A5F-CC483933D3F5",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CCA2B84-62BB-41C6-A65D-C27E4E98AF78",
    "patient_ID": "TCGA.96.A4JL",
    "bcr_drug_barcode": "TCGA-96-A4JL-D40915",
    "bcr_drug_uuid": "5C1CCACD-D745-4D1A-859C-14F1AB3F09CE",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0CCA2B84-62BB-41C6-A65D-C27E4E98AF78",
    "patient_ID": "TCGA.96.A4JL",
    "bcr_drug_barcode": "TCGA-96-A4JL-D40916",
    "bcr_drug_uuid": "30A91173-72F9-42D3-B0D2-64120ACD1E94",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96533D5B-6E44-4D8F-8FD7-270DD4F0362E",
    "patient_ID": "TCGA.98.A53I",
    "bcr_drug_barcode": "TCGA-98-A53I-D42551",
    "bcr_drug_uuid": "565E98AF-F3EE-40F3-B7BD-25430061DF75",
    "form_completion_date": "2014-10-23",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "96533D5B-6E44-4D8F-8FD7-270DD4F0362E",
    "patient_ID": "TCGA.98.A53I",
    "bcr_drug_barcode": "TCGA-98-A53I-D42385",
    "bcr_drug_uuid": "0414D9C9-8737-48C2-B689-C47C5A836525",
    "form_completion_date": "2014-10-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "99DAA971-31D0-4C37-9C12-B0DC42DDD19B",
    "patient_ID": "TCGA.J1.A4AH",
    "bcr_drug_barcode": "TCGA-J1-A4AH-D38847",
    "bcr_drug_uuid": "F8B27C48-03E3-4AFC-B1D3-73DFD0383A30",
    "form_completion_date": "2012-12-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "99DAA971-31D0-4C37-9C12-B0DC42DDD19B",
    "patient_ID": "TCGA.J1.A4AH",
    "bcr_drug_barcode": "TCGA-J1-A4AH-D38850",
    "bcr_drug_uuid": "F96488FF-D720-412E-A208-B10DFB9B7DC6",
    "form_completion_date": "2012-12-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FF7099E1-8FF9-48E4-842D-46E98076E7E6",
    "patient_ID": "TCGA.L3.A524",
    "bcr_drug_barcode": "TCGA-L3-A524-D39419",
    "bcr_drug_uuid": "1E45D553-3C34-4F87-A5A5-8DD5FDEF98C3",
    "form_completion_date": "2013-1-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FF7099E1-8FF9-48E4-842D-46E98076E7E6",
    "patient_ID": "TCGA.L3.A524",
    "bcr_drug_barcode": "TCGA-L3-A524-D39421",
    "bcr_drug_uuid": "F9EA6E0A-8493-4756-B589-F804A5CD806F",
    "form_completion_date": "2013-1-22",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0425CB44-66AF-4E25-AFCB-CACCCC2F1179",
    "patient_ID": "TCGA.LA.A7SW",
    "bcr_drug_barcode": "TCGA-LA-A7SW-D55509",
    "bcr_drug_uuid": "F47DA35E-B337-4F39-B3EE-BCADCE58571E",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0425CB44-66AF-4E25-AFCB-CACCCC2F1179",
    "patient_ID": "TCGA.LA.A7SW",
    "bcr_drug_barcode": "TCGA-LA-A7SW-D55511",
    "bcr_drug_uuid": "32D8C184-BB12-41C0-B0CE-5E0AB491E8AD",
    "form_completion_date": "2014-1-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F247EEF-9C0A-4E7A-A2E8-2A84225BA307",
    "patient_ID": "TCGA.MF.A522",
    "bcr_drug_barcode": "TCGA-MF-A522-D39898",
    "bcr_drug_uuid": "412A4DD8-D3C1-4802-A710-83B5CAB8F6FC",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F247EEF-9C0A-4E7A-A2E8-2A84225BA307",
    "patient_ID": "TCGA.MF.A522",
    "bcr_drug_barcode": "TCGA-MF-A522-D40946",
    "bcr_drug_uuid": "3907157C-0F0E-48A4-B3EB-F5C9E11241FC",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9F247EEF-9C0A-4E7A-A2E8-2A84225BA307",
    "patient_ID": "TCGA.MF.A522",
    "bcr_drug_barcode": "TCGA-MF-A522-D40947",
    "bcr_drug_uuid": "2F15BFAF-E1E1-46DE-8B3E-78DA0526574E",
    "form_completion_date": "2013-3-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5C24C76-2E98-41DF-B17D-B53C0B5E7787",
    "patient_ID": "TCGA.NC.A5HE",
    "bcr_drug_barcode": "TCGA-NC-A5HE-D42295",
    "bcr_drug_uuid": "FE4B2005-3757-4AA2-9CAF-F1D83E2A4FF4",
    "form_completion_date": "2013-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5C24C76-2E98-41DF-B17D-B53C0B5E7787",
    "patient_ID": "TCGA.NC.A5HE",
    "bcr_drug_barcode": "TCGA-NC-A5HE-D42296",
    "bcr_drug_uuid": "F1F12BA9-EF24-472C-804D-ED7FE9E3A2CE",
    "form_completion_date": "2013-4-16",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C179D6B1-6182-48B8-A376-3133E0DEC278",
    "patient_ID": "TCGA.NC.A5HG",
    "bcr_drug_barcode": "TCGA-NC-A5HG-D42334",
    "bcr_drug_uuid": "9A9D8CDF-7F30-4677-9347-DEBA6862878E",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C179D6B1-6182-48B8-A376-3133E0DEC278",
    "patient_ID": "TCGA.NC.A5HG",
    "bcr_drug_barcode": "TCGA-NC-A5HG-D42335",
    "bcr_drug_uuid": "5EDEA676-B589-44C9-81E5-0FC227AB6C6A",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CE7DCB92-13AA-4496-82D2-873B53647BFD",
    "patient_ID": "TCGA.NC.A5HI",
    "bcr_drug_barcode": "TCGA-NC-A5HI-D42340",
    "bcr_drug_uuid": "F9DA1FB6-F8D4-422E-A1DE-20BDE247F02F",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CE7DCB92-13AA-4496-82D2-873B53647BFD",
    "patient_ID": "TCGA.NC.A5HI",
    "bcr_drug_barcode": "TCGA-NC-A5HI-D42341",
    "bcr_drug_uuid": "1693FBB3-505B-4966-8997-30A246462F61",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00FD9306-4A68-49AB-A768-E5FED126A765",
    "patient_ID": "TCGA.NC.A5HJ",
    "bcr_drug_barcode": "TCGA-NC-A5HJ-D42343",
    "bcr_drug_uuid": "5BDAF30B-3C5D-4E1F-9DF5-E790A50F6E7C",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00FD9306-4A68-49AB-A768-E5FED126A765",
    "patient_ID": "TCGA.NC.A5HJ",
    "bcr_drug_barcode": "TCGA-NC-A5HJ-D42344",
    "bcr_drug_uuid": "7FD3D7EC-D66F-49AF-B038-2AA48C175B1B",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 411,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "87410C09-5B61-4F61-85A5-93C288AECA03",
    "patient_ID": "TCGA.NC.A5HK",
    "bcr_drug_barcode": "TCGA-NC-A5HK-D42346",
    "bcr_drug_uuid": "7205AE68-7607-4A15-98EF-47A6DFC9A131",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "87410C09-5B61-4F61-85A5-93C288AECA03",
    "patient_ID": "TCGA.NC.A5HK",
    "bcr_drug_barcode": "TCGA-NC-A5HK-D42347",
    "bcr_drug_uuid": "A75E9E2B-CFE2-486A-ACDF-50C500E65114",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42F86EC9-85A0-4015-990C-BE445F532197",
    "patient_ID": "TCGA.NC.A5HO",
    "bcr_drug_barcode": "TCGA-NC-A5HO-D42352",
    "bcr_drug_uuid": "67C3BB30-C35E-43F2-8429-C101C6339DB4",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42F86EC9-85A0-4015-990C-BE445F532197",
    "patient_ID": "TCGA.NC.A5HO",
    "bcr_drug_barcode": "TCGA-NC-A5HO-D42353",
    "bcr_drug_uuid": "EEBF937A-A339-496C-8041-1F0063771AE9",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A95CE25-D06A-499D-B7EE-AFF5EE94D4F1",
    "patient_ID": "TCGA.NC.A5HP",
    "bcr_drug_barcode": "TCGA-NC-A5HP-D42355",
    "bcr_drug_uuid": "D5D544C4-32F7-4AFA-AB2E-A6BD4BAC381C",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A95CE25-D06A-499D-B7EE-AFF5EE94D4F1",
    "patient_ID": "TCGA.NC.A5HP",
    "bcr_drug_barcode": "TCGA-NC-A5HP-D42356",
    "bcr_drug_uuid": "51755B3E-6D96-4E9C-BA63-A0809B734944",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4A95CE25-D06A-499D-B7EE-AFF5EE94D4F1",
    "patient_ID": "TCGA.NC.A5HP",
    "bcr_drug_barcode": "TCGA-NC-A5HP-D42357",
    "bcr_drug_uuid": "CC1C8E74-D6AB-43D0-ADF3-0C827990EE8E",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 358,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 448,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4A95CE25-D06A-499D-B7EE-AFF5EE94D4F1",
    "patient_ID": "TCGA.NC.A5HP",
    "bcr_drug_barcode": "TCGA-NC-A5HP-D42361",
    "bcr_drug_uuid": "DEB9E9EB-C2C6-428A-8F0B-F0855240E59F",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 540,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 632,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4A95CE25-D06A-499D-B7EE-AFF5EE94D4F1",
    "patient_ID": "TCGA.NC.A5HP",
    "bcr_drug_barcode": "TCGA-NC-A5HP-D42363",
    "bcr_drug_uuid": "DB3CE80F-CE23-4605-B08E-87370A462712",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 632,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4B185183-7E94-4AAB-B19D-6A2E48B85A5D",
    "patient_ID": "TCGA.NC.A5HQ",
    "bcr_drug_barcode": "TCGA-NC-A5HQ-D42366",
    "bcr_drug_uuid": "6E87E526-B071-4045-8020-32DF9FB85B37",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4B185183-7E94-4AAB-B19D-6A2E48B85A5D",
    "patient_ID": "TCGA.NC.A5HQ",
    "bcr_drug_barcode": "TCGA-NC-A5HQ-D42367",
    "bcr_drug_uuid": "31E83691-F98F-4984-BA4E-4E0BEC7C32BD",
    "form_completion_date": "2013-4-17",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "169B32F1-4371-464C-AC94-22B7D7389403",
    "patient_ID": "TCGA.NC.A5HR",
    "bcr_drug_barcode": "TCGA-NC-A5HR-D42427",
    "bcr_drug_uuid": "308D6357-E699-46D7-B218-B99D1E748107",
    "form_completion_date": "2013-4-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "169B32F1-4371-464C-AC94-22B7D7389403",
    "patient_ID": "TCGA.NC.A5HR",
    "bcr_drug_barcode": "TCGA-NC-A5HR-D42428",
    "bcr_drug_uuid": "56ED8DA4-1528-4A84-80B7-B075B1D18949",
    "form_completion_date": "2013-4-19",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8BA2CF7B-E474-4ABA-8C6D-9FD36F5C6759",
    "patient_ID": "TCGA.NC.A5HT",
    "bcr_drug_barcode": "TCGA-NC-A5HT-D42431",
    "bcr_drug_uuid": "2F85726E-8C4F-4413-B730-57492E8BC231",
    "form_completion_date": "2013-4-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8BA2CF7B-E474-4ABA-8C6D-9FD36F5C6759",
    "patient_ID": "TCGA.NC.A5HT",
    "bcr_drug_barcode": "TCGA-NC-A5HT-D42432",
    "bcr_drug_uuid": "FDA9D83B-436C-4EEE-9983-D7F82CEE7E8B",
    "form_completion_date": "2013-4-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8BA2CF7B-E474-4ABA-8C6D-9FD36F5C6759",
    "patient_ID": "TCGA.NC.A5HT",
    "bcr_drug_barcode": "TCGA-NC-A5HT-D55769",
    "bcr_drug_uuid": "47DA8CF7-D95A-4240-B9EA-5CCF9F364C9D",
    "form_completion_date": "2014-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 677,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8BA2CF7B-E474-4ABA-8C6D-9FD36F5C6759",
    "patient_ID": "TCGA.NC.A5HT",
    "bcr_drug_barcode": "TCGA-NC-A5HT-D55777",
    "bcr_drug_uuid": "4DEF5FBD-F30E-4683-9D09-D5B04A9413B3",
    "form_completion_date": "2014-1-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 677,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "80AA8E99-41D5-422F-A1BB-69599AA8236F",
    "patient_ID": "TCGA.NK.A5D1",
    "bcr_drug_barcode": "TCGA-NK-A5D1-D69590",
    "bcr_drug_uuid": "F01A9272-D487-40C9-B709-1A721A0061D7",
    "form_completion_date": "2015-1-14",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "80AA8E99-41D5-422F-A1BB-69599AA8236F",
    "patient_ID": "TCGA.NK.A5D1",
    "bcr_drug_barcode": "TCGA-NK-A5D1-D69591",
    "bcr_drug_uuid": "79275F84-FD95-47AF-8015-E48B49ED5194",
    "form_completion_date": "2015-1-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 476,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
